Image quality and radiation dose comparison of a computed radiography system and an amorphous silicon flat panel system in paediatric radiography: a phantom study by Irvine, M
lmage Quality and Radiation Dose Comparison of a
Computed Radiography System and an Amorphous
Silicon Flat Panel System in Paediatric
Radiography: A Phantom Study
M.A. lrvine
(Master of Applied Science)
2009
RMIT
lmage Quality and Radiation Dose Comparison of a
Computed Radiography System and an Amorphous
Silicon Flat Panel System in Paediatric
Radiography: A Phantom Study
A thesis submitted in partial fulfilment of the requirements for the
degree of Master of Applied Science
Michael A. lrvine
B.Sc.
School of Applied Sciences
Science, Engineering and Technology Portfolio
ü:ily,ivers 
tv
Declaration
I certify that except where due acknowledgment has been made, the work is
of the author alone; the work has not been submitted previously, in whole or
part, to qualify for any other academic award; the content of the thesis is the
result of work that has been carried out since the official commencement date
of the approved research program; and, any editorial work, paid or unpaid,
carried out by a third part is acknowledged.
Michael A. lrvine
28 January 2009
Acknowledgments
For their astute guidance in overseeing this work, thank you to my supervisors,
Professor Peter Johnston and Dr Andrew Campbell. Your invaluable input is very
much appreciated!
I would also like to thank Mr lan Morris, Ms Wendy Wheatley and their staff at
Princess Margaret Hospital for Children, for their advice on the clinical aspects of this
work and allowing me seemingly never-ending access to their department's X-ray
rooms.
Finally, thank you to Mr Ed Scull, Dr David Causer and their staff from the
Department of Medical Engineering Physics at Royal Perth Hospital for supporting
this project both professionally and financially.
Abstract
This purpose of this work was to investigate the patient radiation doses and image
quality of a Philips/Agfa computed radiographic (CR) system and a Philips indirect-
capture digital radiographic (DR) system in a paediatric setting. A CDRAD digital
radiographic contrast-detail phantom was used to assess radiographic image quality.
The CDRAD phantom contains targets of gradually changing size and contrast that,
when imaged in conjunction with Perspex slabs to simulate the dimensions of a
patient, provides information about the imaging performance of the radiographic
system. Perspex slabs of three different thicknesses (6, 1 1 and 16 cm) were used to
simulate paediatric patients of three arbitrary ages. These phantoms, in conjunction
with the CDRAD digital radiographic contrast-detail phantom, were imaged under
three different conditions. The CDRAD Analyser software package was used to
assess the quality of each image, rather than assessments being made by human
observers. This allowed objective comparisons of images, the quality of the images
to be more easily quantified and a reduction in human labour.
The first experiment conducted was a comparison of the two systems under standard
conditions. This meant that in addition to the fixed filtration of the X-ray tube,
additional beam filtration of aluminium and copper, as recommended in European
Guidelines on Quality Criteria for Diagnostic Radiographic lmages in Paediatrics,
was employed for both systems (European Commission 1996b). lmage quality was
compared for each phantom size at three doses with the same entrance exposure
used for both systems. The entrance exposures used were those determined by
using the CR system's automatic exposure control system. A visual comparison of
the resulting contrast detail curves showed the DR system generally outperformed
the CR system, especially at the lowest two doses. The image quality figures
(lQF¡nu,), calculated by the CDRAD Analyser software and which provide an overall
measure of image quality, were also generally higher for the DR system. A chi-
square analysis of the targets detected showed the DR system to be significantly
better than the CR system in all three cases at the lowest dose, two of three at the
intermediate dose and one of three at the highest dose level. ln the other cases the
DR and CR system performance was similar.
The second experiment performed was to compare the two systems under the
conditions used in routine clinical practice at PMH. This experiment was conducted
because at this institution the filtration used for the CR and DR systems generally
differed from that normally recommended for paediatric radiography. With the CR
system, additional filtration was only employed clinically for the largest patients,
corresponding to the thickest phantom in this experiment. For these patients,
hafnium was used in addition to the inherent X-ray tube filtration. For the DR system,
additional aluminium is used clinically for all but the largest patients, where
aluminium and copper is used. Due to the varying levels of beam filtration in place,
X-ray beam spectra differed considerably between the CR and DR systems. This
meant that unlike the experiment under standard conditions, the exposures used
were optimised independently for each X-ray system.
For the two smaller phantom sizes, not using additional filtration meant that the
image quality of the CR system was comparable or better than the DR system. The
chi-square analysis of the targets detected showed the CR system to be significantly
better than the DR system at two of three doses for the thinnest phantom and no
significant difference at any doses for the intermediate phantom size. The lack of
additional filtration for the CR system had a major dose cost, with the softer X-ray
beam resulting in the CR effective doses being higher by between 38% and 100%.
For the largest phantom size, additional filtration 
- 
although different 
- 
was used for
the CR and DR systems and so the X-ray beam spectra were more similar.
Consequently, the results for this phantom size reflected those from the experiment
conducted under standard conditions, ie the effective doses for both systems were
similar and the image quality of the DR system superior. The chi-square analysis
showed the DR system to be significantly better than the CR at all three dose levels.
A third experiment was undertaken to compare doses between the two systems at
'equal' image quality. lmage quality is a difficult parameter to quantify but in this work
it was estimated using the IQF¡nu image quality figure calculated by the CDRAD
Analyser software. IQF¡nu, was held constant for both systems and the entrance
exposures required to achieve this image quality were measured and then converted
to effective doses using the dose calculation software package PCXMC 1.5. The DR
system offered effective dose savings of between 28 and 42o/o for the three phantom
sizes.
Overall, this work suggests that a Philips flat-panel system is superior to an Agfa CR
system in paediatric radiography. This result generally reflects the findings of other
authors who have conducted similar studies in adult patient settings.
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1. lntroduction
X-rays have been used to obtain anatomical images of the human body for more
than 100 years. X-rays are a type of electromagnetic radiation with wavelengths
typically in the range of 10-12 
- 
10-e metres, as shown in Figure 1. Like all ionising
radiation, X-rays have sufficient energy to eject electrons from the valance shells of
atoms and molecules and are therefore capable of damaging tissue.
Spøctrurn of ßodiotion €nørgy
10-1+ 10-É 10-1o 10-e¡.t0-6 10-+ l0-a 1
Vbbb llghl
Figure 1. The electromagnetic radiation spectrum (Adcock 1999).
Radiation effects may be somatic (acute or late) or genetic. Acute effects occur soon
after the radiation exposure, have a threshold dose before the effect occurs and the
severity of the effect increases with radiation dose. Some examples are cataracts,
erythema and death. Late effects (primarily cancer induction) are considered to be
stochastic (random) in nature and are assumed to occur without a threshold dose.
The probability of the effect occurring is hypothesised to increase linearly with dose
(The lnternational Commission on Radiological Protection 1991).
The process of using X-rays to obtain anatomical images in diagnostic radiology
involves a complex interdependence of many factors. The aim is to obtain an image
that is adequate for the clinical purpose, whilst minimising the radiation dose to the
patient. ln properly-conducted diagnostic X-ray examinations, acute radiation effects
do not occur because the radiation doses are well below the threshold for these
effects (The lnternational Commission on Radiological Protection 1982). A possible
exception to this is in lengthy interventional fluoroscopic procedures. More of a
concern are late effects; primarily fatal and non-fatal cancer induction (The
lnternational Commission on Radiation Units and Measurements 2005). ln the
management of radiation risk, the total risk of lethal cancer is assumed to be
dependent on the sum of weighted, individual organ doses. This measure is termed
'effective dose' and will be discussed later in the chapter. The need to minimise
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rad¡ation doses is particularly important in paediatric radiology, as children are more
sensitive to ionising radiation than adults. This is due to the fast-growing tissues in
children being more sensitive to radiation and the greater chance that the cancer's
latent period will occur within their lifetime (The lnternational Commission on
Radiological Protection 1991). This study investigates the image quality and
radiation dose of two different radiographic X-ray systems used routinely in paediatric
radiology.
The optimal use of ionising radiation for radiographic imaging involves three
important aspects: the diagnostic quality of the radiographic image, the radiation
dose to the patient and the choice of radiographic technique (European Commission
1996a). Better quality images can often be obtained using imaging techniques that
deliver a higher radiation dose, in which case this should be weighed against the
increased risk from exposure to the radiation. As an example, should a change in
protocol for a particular examination produce a reduction of 1 mSv in effective dose,
this may lower the risk of a radiation induced fatal cancer by about 1 in 30 000. lf,
however, this causes one potentially malignanttumourto be missed in every 10 000
patients, a net increase in the risk to the patient will result (Martin, Sutton & Sharp
1 eee).
ln situations where there is a trade-off between patient dose and image quality, both
quantities need to be measured. lnformed choices need to be made to achieve the
required image with the minimum dose. This process involves consideration of many
interdependent factors, some of which are quantifiable, whilst other, such as
radiological interpretation, are more subjective (Martin, Sharp & Sutton 1999).
Chapter 2 thal follows is the literature review. lt describes each step in the imaging
chain, from generation of the X-ray beam to interpretation of the medically relevant
features contained within the final image and provides an overview of the work of
other authors who have investigated radiation dose and/or image quality in diagnostic
radiography. Chapter 3 outlines the materials and methods used for the three
experiments conducted, namely, an image quality comparison under standard
conditions, a similar experiment conducted under the clinical conditions at Princess
Margaret Hospitalfor Children and thirdly, a patient dose comparison under standard
conditions. Chapters 4, 5 and 6 contain both the result and discussion sections for
these three experiments, respectively. Chapter 7 provides the conclusions reached
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from this work, chapter B the references, chapter 9 the glossary and chapters 10, 11
and 12 the appendices.
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2.
2.1 X.RAY GENERATION
Literature Review
The main mechanism for production of X-rays is via Bremsstrahlung radiation,
produced by the deceleration of electrons. The name 'Bremsstrahlung' comes from
the German term for braking. The production of Bremsstrahlung X-radiation is most
often performed by acceleration of electrons, followed by colliding them with a metal
target, whereby the electrons are deflected from their original path by electrostatic
forces and in the process, produce the Bremsstrahlung X-radiation. ln diagnostic
radiology applications this is done in an X-ray tube assembly, which consists of a
housing 
- 
sometimes oil-filled 
- 
containing an X-ray tube insert (Bushberg et al.
2002).
ln order to accelerate the electrons, a generator is used to transform and rectify
'mains' alternating current (AC) to a high voltage direct current (DC), which is applied
to the X-ray tube. The X-ray tube itself consists of an evacuated tube containing a
cathode, with one or more filaments within a beam focussing block, and an anode.
The anode must withstand extreme heat, so tungsten is often used, due to its high
melting point (3410 "C). A typical X-ray tube is shown in Figure 2. X-rays are
produced when the electric field is applied between cathode and anode, causing
electrons to flow from the cathode filament to the anode. Upon striking the anode,
the electrons lose energy through three means: heat (accounting for the vast majority
of energy loss), Bremsstrahlung X-radiation and characteristic (of the target material)
X-radiation (Adcock 1999). The tube housing protects the tube and is usually
shielded with lead to contain leakage radiation 
- 
X-rays that escape in unwanted
directions 
- 
whilst oil within the housing may be used to dissípate heat and provide
electrical insulation.
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Figure 2. A typical X-ray tube with rotating anode (Aichinger et al. 2004).
Bremsstrahlung X-radiation allows X-ray imaging to be a tremendously useful tool.
The energy of the photons produced primarily depends on the amount of energy lost
by the impinging electrons. X-rays are produced with energies ranging from zero to
an energy equal to the tube voltage 
- 
the potential difference across the tube. The
maximum photon energy is:
Emax = e.U Equation 1
where e is the elementary charge (1.6x10'1e C) and U is the potential difference
across the X-ray tube. The resulting X-ray spectra depend predominantly on the
tube voltage applied, the waveform of the tube voltage, the anode material and any
filtration placed in the beam (Aichinger et al. 2004).
X-ray tubes have an exit window, which is a thin part of the tube in a direct line
between the anode and the area to be imaged. As X-rays diverge in all directions
from the point of production, some pass through the exit window, and form the
primary radiation beam used for imaging, whilst most others are absorbed by the
housing. The size and shape of the primary X-ray beam is normally controlled by a
collimator 
- 
two sets (x and y directions) of opposing, adjustable lead jaws (Bushberg
et al. 2002).
ln all but the smallest of X-ray tubes, the anode rotates, which allows the electrons to
interact with a larger surface area, increasing heat dissipation. X-ray tubes with
rotating anodes can therefore withstand much higher electrical power input (usually
referred to as 'tube loading'). The target area of the anode is called the focal spot
and is an important factor affecting image quality (sharpness), due to its part in the
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imaging geometry. Rather than a focal spot, rotating anodes have a focal spot track,
being the target area throughout the anode's 360' rotation. Anodes can have up to
three focal spots, each of a different size. Each consists of a bevelled edge to
provide a square (like) optical focal spot, but a rectangular electrical focal spot (line
focus principle) for a larger surface area and increased heat loading potential
(Aichinger et al. 2004). This principle is demonstrated in Figure 3. The length of the
focal spot is mainly governed by the filament length and anode angle, whilst the width
of the focal spot is governed by the diameter of the filament coil and the width of the
focussing slot.
A
Large anode angle
Small filament length
B
Large anode angle
Long filament lenglh
c
Small anode angle
Long filament length
Projected
Focal Spot
Good field coverage Good field coverage Poor field coverage
Small effective focal spot Large effective focal spot Small effective fpcal spot
Poor power loading Good power loading Good power loading
Figure 3. The line-focus principle is illustrated, showing the effect of anode angle on
effective focal spot size, The effect of filament length is also demonstrated (Bushberg
et a|.2002).
One or more filters may be placed in the path of the X-ray beam to absorb low
energy photons. Aluminium, with a K-shell absorption edge at 1.55 keV, is often
used. The filters are typically placed immediately adjacent to the exit window of the
tube housing, and remove low energy photons that would othen¡vise contribute to the
patient's radiation dose but not have sufficient energy to penetrate the patient and
contribute diagnostically relevant information to the image. ln removing low energy
photons, filters raise the mean photon energy of the X-ray beam spectrum (radiation
quality), but at the same time reduce the total number of photons in the beam
(Martin, Sutton & Sharp 1999).
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There are three main factors in which there is a trade-off between image quality and
X-ray dose - beam quality, removal of scattered radiation and photon fluence (Martin,
Sutton & Sharp 1999).
Photon fluence (O) is the number of photons, irrespective of energy, incident on a
sphere of cross-sectional area, so:
Equation 2
where dN is the number of photons and da is the cross-sectional area. The
distribution of the fluence with respect to the number of photons of energy E is given
by:
@¿= dE da.dE Equation 3
where Oe is the fluence d<Þ of photons of energy between E and E + dE. Radiation
quality is governed by the physical characteristics of the radiation source and the
selected exposure parameters. These include the anode material of the X-ray tube,
filtration material and thickness, the peak tube voltage selected, its temporal course
(especially for short exposure times or, in pulsed exposure techniques its rise and
drop) and the inherent waveform of the tube voltage (2-,6-,12-, multi-pulse or DC).
The resultant radiation quality influences both patient dose and image quality
(Bushberg et al. 2002).
2.2 X.RAY BEAM QUALITY
An increase in the X-ray tube voltage (for a particular anode-filter combination and at
a set image receptor dose) will increase the mean photon energy (quality) of the X-
ray spectrum and consequently the penetrating power of the beam. lf dose at the
image receptor is kept constant, this results in reduced patient dose and a reduction
in the image contrast (Martin, Sutton & Sharp 1999). The aforementioned authors
detail radiographic projections in which significant reductions in patient dose are
achieved using higher tube voltages, with lower contrast but still with clinically
acceptable images. Beam quality is measured as the half value layer (HVL), the
thickness of a specified material (usually aluminium) which attenuates the X-ray
beam to such an extent that the beam's intensity is reduced to half of the
dN
d,o-
dNda
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unattenuated intensity. Higher quality X-ray beams generally result in reduced image
contrast (Aichinger et al. 2004).
Materials of higher atomic number than aluminium, which have larger photoelectric
cross-sections, are sometimes used to remove more of the low-energy X-rays from
the beam. Copper, with a K edge at 9 keV, is commonly used in addition to
aluminium to remove photons with energies between 20 and 40 keV, which
contribute significantly to patient dose, but not to the image. The major disadvantage
of copperas a filtermaterial is increased tube loading (Martin, Sutton & Sharp 1999).
Both the patient dose reductions and increased tube loadings are emphasised further
when materials such as yttrium and niobium are used, with K edges of about 20 keV.
ln addition to the standard inherent filtration (typically equivalent to 2.5 mm
aluminium for standard radiographic X-ray tubes), the use of an additional 1 mm Al
and 0.1 
- 
0.2 mm copper filtration or equivalent is recommended in European
Guidelines on Quality Criteria for Diagnostic Radiographic lmages in Paediatrics for
most radiographic projections (European Commission 1996b). ln paediatric
radiology, tube loading is less of an issue and patient dose more important.
Although the entrance dose (to be discussed shortly) decreases fairly rapidly with
increasing filtration, this is generally not the case for the organs, where the mid-line
dose within the primary beam decreases much less rapidly than the entrance surface
dose. Mid-line doses outside the radiation field have even been observed to
increase at higherfiltration due to increases in lateral scatter (Aichinger et al. 2004).
2.3 BEAM INTERACT¡ON WITH THE IMAGED OBJECT AND ANCILLARY
ITEMS
The radiographic image is a two dimensional projection of the attenuating properties
of the tissues within the field of view. The attenuation properties of the various kinds
of tissue in the patient's body, with respect to X-ray photons in the diagnostic energy
range, is determined principally by the photoelectric effect and Compton-scattering.
Photons that enter the patient may be absorbed, transmitted without interaction
(primary photons) or scattered (secondary photons). A scattered photon that
reaches the image receptor has been deflected from its original course, so upon
striking the image receptor, contributes spatially incorrect information about the
attenuation that occurred along its path. ln this way, scattered photons add noise to
images. lmages produced by beams from which there is a high proportion of
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photoelectric interactions (and less Compton scatter) will therefore give better image
contrast and be less noisy (Martin, Sutton & Sharp 1999).
lntermediate layers in the beam path, such as the table, anti-scatter grid, automatic
exposure control detector and image receptor cover, all attenuate the X-ray beam to
some degree and so contribute to increased radiation exposure of the patient
(Aichinger et al. 2004). The attenuation effect of any particular layer is characterised
by an attenuation factor at a specific radiation quality and measuring arrangement, or
by an Al attenuation equivalent.
It is the differing amount of attenuation of X-radiation by the body's tissues, as a
result of differing effective linear attenuation coefficients (p) and tissue thicknesses,
that allows creation of the 'radiation image'. The greater the difference in these
properties, the higher the image contrast will be. This effect is however reduced by
any scattered photons generated as the beam passes through the patient (Aichinger
et al. 2004).
Exposure factors must be matched to the particular examination being conducted to
optimise image quality and patient radiation dose. For instance, in mammography,
the linear attenuation coefficients for the tissues of interest decrease rapidly with
increasing energy and the difference between them is very small. For these reasons,
low tube voltages of 25-35 kV are needed in order to achieve sufficient contrast for
diagnosis (Aichinger et al. 2004). However, lower tube voltages result in increased
patient dose and are therefore only used when absolutely necessary. The inverse
situation occurs in chest radiography, where high tube voltages >100 kV are used to
compensate for overlapping tissues with very different linear attenuation coefficients;
the ribs, spine, mediastinum and lung tissue.
ln radiographic arrangements where the image receptor is placed behind the table
with respect to the patient, the tabletop must be strong, made of low-aüenuation
material and free from artefact-causing materials, with carbon fibre being the gold
standard. An attenuation equivalent to 1 mm of Al or less can be attained in a table
top consisting of layers of carbon fire and foam (Aichinger et a|.2004).
ln diagnostic radiology, a grid is the most commonly used tool to reduce scatter at
the image receptor and to improve image contrast. Grids are essentially interspaced
absorbing strips (usually lead) and may be (1) focussed, where the strips are in
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alignment with the direction to the focal spot so that the attenuation of the image-
forming primary radiation is as low as possible, (2) parallel, where the strips are
parallel to each other or (3) crossed, where two linear grids (in the X and Y planes)
are built together. A focussed grid is illustrated in Figure 4.
x-ray tube
pat¡ent
grid
image receptor
Figure 4. Schematic drawing of transmission or absorption of primary and some
secondary (scattered) photons through a focussed grid.
Despite removing scattered photons from the beam, grids also absorb a proportion of
primary photons. As a result, grids increase the patient's radiation exposure by as
much as a factor of 2-4 (Martin, Sutton & Sharp 1999). To compensate for this, a
higher entrance dose (discussed later) must be applied. Grids are described in terms
of their ratio and line density, eg. B/40. The ratio (B) is defined as:
Equation 4
where h is the height of the lead strips and D is the thickness of the interspace
material, usually paper, aluminium or carbon fibre. The grid's line density (40 in the
above example) in grid lines per centimetre is defined as:
^/- Equation 5D+d
where d is the thickness of the absorbing strips.
h
D
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The use of grids in radiography of infants and young children is often unnecessary as
radiation scatter is low, but when required (eg for older children), an B ratio, 40
line/cm (moving) or >60 line/cm (non-moving) grid is usually sufficient (European
Commission 1996b). Because reduced contrast due to scatter can be corrected
post-exposure in digital radiography, the role of grids in digital imaging may be
reduced further (Neitzel 2004). This is discussed further in section 2.7 .2.1.
Alternative scatter reduction approaches include the air-gap technique, where a gap
is left between patient and image receptor in order to increase the likelihood that
scattered radiation will miss the image receptor, shown in Figure 5. A larger source-
image-distance (SlD) of 3-4 m is necessary to reduce magnification, resulting from
beam divergence, and hence tube loading is increased in proportion to the inverse of
the square of the change in SID 
- 
the inverse square law. Resolution of small image
details can be made better or worse, depending on their location within the patient's
body (Aichinger et al.2004).
Figure 5. Air gap technlque sometimes used in chest radiography (Adcock 1999).
Many radiographic examinations conducted with 'fixed'X-ray units use an automatic
exposure control (AEC) system, which terminates the exposure at a pre-defined
optical density or brightness. This is usually achieved by the AEC system having one
or more ionisation chambers that measure the dose during the exposure. ln this
way, the exposure is automatically terminated at a preset dose that corresponds to
the required optical density or brightness. The chamber is normally positioned
behind the anti-scatter grid but in front of the image receptor and so must be 'shadow
free' to prevent artefacts and attenuate as little of the imaging beam as possible. The
chamber usually has an electrode coated with a very thin layer of metal (often lead).
During the exposure, photoelectrons are released from the metal layer and ionise the
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air within the chamber. This makes the detector much more sensitive than if it relied
on the air volume being directly ionised by the impinging photons. The attenuation
by a detector of such a design is about 4-5o/o at B0 kV (Aichinger et al. 2004).
The imaging geometry of radiographic installations has great influence on patient
exposure and image quality. At constant exposure factors, radiation dose changes
with SID according to the inverse square law. Therefore, to maintain a constant dose
to the image receptor whilst altering the SlD, the X-ray tube output needs to be
altered exponentially. When the air-gap scatter reduction technique is used and for a
given distance between the focal spot and the patient's entrance surface, the patient
dose also increases with increasing air-gap size according to the inverse square law.
2.4 RADIATION DOSE AND DOSIMETRY
ln Western Australia, the legislation on the use of radiation in medicine is consistent
with the lnternational Commission on Radiological Protection's recommendations.
Radiation protection in medicine is governed by the Radiation Safety Act 1975, under
which a statutory body known as the Radiological Council is established. The other
legislation of relevance is the Radiation Safety (General) Regulations 1983 - 2001.
Currently, most of this legislation is based on the ICRP's publication 60, 1990
recommendations of the ICRP. A replacement report, ICRP 103, has recently been
released (The lnternational Commission on Radiologícal Protection 2007). The
recommendations in this new report will no doubt cause some changes to existing
legislation around the world.
2.4.1 Patient dose
There are no set dose limits for patients; however, according to the internationally
recognised ALARA principle, doses should be kept as low as reasonably achievable
with social and economic factors taken into account (The lnternational Commission
on Radiological Protection 2007). There are essentially two reasons for determining
patient radiation doses, firstly so that the radiation risk may be estimated and
secondly, to allow comparison with other X-ray systems or techniques.
There are a few primary dosimetric quantities concerned with the radiography sub-
field of diagnostic radiology: exposure (X) is a measure of the ionisation of air, with
the Sl unit being coulombs per kilogram but with the older unit, roentgens (R), still in
common use. lt is a measure of the absolute value of the total charge of the ions of
one sign produced in air when all the electrons and positrons liberated or created by
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photons in air are stopped completely in a mass of air. lt is measured using an
ionisation chamber connected to an electrometer. According to the ICRU, entrance
surface exposure (ESE) is the exposure at the entrance surface, free in air, ie not
including backscatter from a patienVphantom (The lnternational Commission on
Radiation Units and Measurements 2005). Absorbed dose is the energy deposited in
a material, the unit being the Gray (Gy), which is one J/Kg. KERMA (K) is the kinetic
energy released in a material, usually air, by ionising radiation, with the unit also
being the Gray. The two measures are slightly different dosimetric quantities but the
difference is negligible at diagnostic X-ray energies (The lnternational Commission
on Radiation Units and Measurements 2005). To avoid ambiguity, the descriptors
'incident' (no backscatter) or 'entrance surface' (including backscatter) should be
included (The lnternational Commission on Radiation Units and Measurements
2005). This may be done by adding 'i' or 'e' to the relevant symbol. When
performing measurements using an ionisation chamber, the ICRU suggests that
KERMA is a more appropriate unit than absorbed dose but when using solid state
dosemeters, thermoluminescent dosimeters (TLDs) etc, absorbed dose is the more
appropriate unit (The lnternational Commission on Radiation Units and
Measurements 2005). Ki is often found by measuring the ESE using an ionisation
chamber and then converting to K¡ using the exposure/KERMA conversion factor for
the detector material (air).
Some ambiguity and inconsistency does exist in the literature, including between the
ICRU, AAPM and published methods, such as in Aichinger et al, over the use of the
terms KERMA and dose and whether quantities measured at an entrance surface
include backscattered radiation from the phantom/patient. Backscattered radiation
can mean a difference of 25-6Ù0/o in exposure/dose (The lnternational Commission
on Radiation Units and Measurements 2005).
When measuring ESE under experimental conditions reflective of clinical practice, a
patient-equivalent phantom (discussed later) is usually used. The ESE should be
measured at a distance of at least 23cm above the phantom surface to minimise
backscatter and then corrected according to the inverse square law back to the
entrance surface. The ionisation chamber should be placed as close as possible to
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the central axis of the X-ray tube to minimise the heel effectl and not placed in line
with the AEC detectors (American Association of Physicists in Medicine 1990).
Organ doses may be estimated from the ESE, KERMA or absorbed dose by applying
a conversion factor found in readily available tables of data based on Monte Carlo
simulations or by input into dose calculation software. Such methods take the X-ray
beam spectra, projection, patient specifics and field size into account.
As discussed earlier in the chapter, cancer induction following exposure to ionising
radiation is considered to be a stochastic effect, with the risk being proportional to the
dose received. Effective dose, for which the units are Sieverts (Sv), provides an
estimate of the risk of stochastic effects, which is primarily the risk of a fatal cancer
developing due to radiation exposure. Effective dose is usually the parameter quoted
when comparing the radiation dose of different procedures, for ethics approvals and
for estimating the risk of a procedure utilising radiation. According to the ICRP's
latest report (103), the risk of developing cancer in the whole population is 5.5% per
Sievert. The total aggregated detriment (including the probability of severe
hereditary disorders) is 5.7Yo per Sievert (The lnternational Commission on
Radiological Protection 2007). Effective doses may be calculated by multiplying
individual organ doses by their relevant weighting factors (published by the ICRP)
and summing them. The organ doses are most accurately measured by exposing an
anthropomorphic phantom with TLDs appropriately placed for the radiological
examination of interest. Effective dose may also be estimated directly from K¡, or
more crudely using X-ray exposure factors, as inputs into Monte Carlo based dose
calculation software.
Whilst not providing a direct indication of risk, the skin dose may be used as an
indicator of effective dose for a particular projection and is still important in relation to
the deterministic effect erythema (Martin, Sutton & Sharp 1999). As discussed in
chapter 1, deterministic effects are those forwhich there is a threshold dose before
the effect occurs and where the severity increases with dose.
1 The gradual reduction in the intensity - but increase in mean photon energy - of the x-ray beam
towards the anode edge of an x-ray field, due to anode angle.
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2.4.2 Ooerator dose
Occupational and public exposure to radiation is subject to legislative control in the
Western Australian Radiation Safety Act 1975 and its Regulations. The legislation
specifies in detail the requirements to which diagnostic X-ray equipment must
comply, effective annual dose limits for members of the general public and 'radiation
workers', along with numerous other operational and equipment requirements.
The annual effective dose limit for a radiation worker (someone operating X-ray
equipment as part of their duties) is 20 mSv per annum averaged over five years and
a maximum of 50 mSv in any one year. For a member of the public the limit is 1 mSv
per annum averaged over five years and a maximum of 5 mSv in any one year
(Government of Western Australia 2003). These dose limits were taken directly from
those recommended by the ICRP.
Diagnostic X-ray equipment used on humans in Western Australia is subject to
periodic compliance testing, which assesses many things that can affect patient or
operator dose and image quality. Such testing includes the accuracy of exposure
factors, beam quality, AEC performance, light beam collimator (LBC) accuracy and
the amount of leakage radiation emanating from the X-ray tube housing and LBC.
2.5 PATIENT SIMULATION
Physical dosimetry phantoms are used to simulate the way ionising radiation is
absorbed and scattered in a patient, or part of a patient (The lnternational
Commission on Radiation Units and Measurements 2005). When measuring image
quality, an absorber needs to be placed in the beam to represent the relevant body
part. Both can be achieved simultaneously by using various materials, ranging in
simplicity of use and patient equivalence. An anthropomorphic phantom such as
RANDO is the most accurate way of simulating a patient, however, care should be
taken because some phantoms are designed to have equivalent radiation transport
properties to a human being at therapeutic (not diagnostic) energies (American
Association of Physicists in Medicine 1990). They can also be awkward to use. ln
situations where X-ray systems are being tested or compared, it usually sufficient,
and far easier, to use a thickness of some material. A couple of millimetres of copper
or a couple of centimetres of aluminium placed on the X-ray tube does a reasonable
job of patient-like absorption, however, it does nothing to represent clinical scatter
conditions. The most ideal material for a patient equivalent phantom (PEP) is an
appropriate thickness of water (20cm in the case of an adult abdomen) placed at the
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patient position. Liquids can be difficult to contain, however, and water may be an
electrical shock risk in some cases. Of the more convenient materials available for
use, polymethyl methacrylate (PMMA) is commonly used and is fairly tissue-
equivalent at diagnostic X-ray energies (American Association of Physicists in
Medicine f 990). When an appropriate thickness, combined with some aluminium (to
represent bone), is placed in the patient position, entrance/exit doses and scatter
conditions representative of clinical practice can be replicated.
Reports such as AAPM Report No. 31 - Standardised Methods for Measuring
Diagnostic X-ray Exposures - are readily available that specify the appropriate
thicknesses of PMMA and aluminium 
- 
and air gap for a chest 
- 
for various adult
projections. Such reports could not be found for paediatric projections, however, a
number of authors have used PMMA to simulate paediatric patients. (Lopez et al.
2000) used 3.5cm for a newborn chest, 8.5cm for five-month-old pelvis, Bcm for a
five-year-old chest, 1Ocm for a five-year-old pelvis and 1 1.5cm for a five-year-old
abdomen. (Geiser, Huda & Gkanatsios 1996) used 1Ocm of PMMA to represent a
paediatric patient in a study of the effect of patient support pads on image quality and
dose in fluoroscopy. ln a study of automated fluoroscopic systems, Lu et al used
acrylic sheets of 5 
- 
20cm thickness to simulate paediatric patients (Lu et al. 2005).
2.6 IMAGE QUALITY PARAMETERS
A diagnostic image is only useful if the clinical information required is contained in the
image and can be interpreted by the observer. To this end aesthetic appeal is
unimportant (Martin, Sutton & Sharp 1999). Radiological images are displayed as
variations in optical density (OD) of the film (radiograph) or as grey-scale values on
the display screen (digital image), and represent a projection of the spatial absorption
of the patient tissue components within the field of view. For diagnosis, the
structures of interest need to be distinguishable from the background, with the
difference between the two being referred to as the signal (Bushberg et al.2O02).
The quality of various components of the imaging chain (eg focal spot, imaging
geometry, image receptor, video camera and amplifier, image-processing software,
image display) also influence the image signal obtained at the viewing station. These
factors must be taken into account when considering optimisation of image quality
and exposure. The physical characteristics of the X-ray tube assembly and other
components of the whole imaging system must be adapted to the specific
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requ¡rements of the investigation, in order that an optimum image is produced at the
lowest practicable patient dose (Aichinger et al.2004).
The three important aspects of radiological signal are the contrast, sharpness and
noise (Aichinger et al. 2004). The contrast is the difference in optical density (or
brightness) between the object and its surroundings, initially in the radiation image
and after interaction with the image receptor, in the image contrast. The contrast
resolution is the capability of the system to transform subtle tissue density differences
into information within the image and can be expressed as:
c =).{a,* - p2,"î).d =).o*u.o Equation 6
where p1sff ând p2e6 ârê the effective linear attenuation coefficients of the detail and
its surroundings, respectively and d is the detail thickness. The sharpness is the
density gradient transition between an object and surroundings, so a sharp image
has a steep edge gradient transition between object and surroundings. Sharpness or
MTF can be quantitatively defined using the frequency specific modulation transfer
function (MTF( v )). ln the analysis of imaging systems, MTF( v ) is used to express
the transfer of the image signal amplitude at each spatial frequency (v); the better
the contrast transfer at high spatial frequencies, the smaller are the image details that
can be recognised separately in the image. MTF(v) is usually measured by
determining the line spread function by imaging a narrow jaw slit, performing a one-
dimensional Fourier transformation and then normalising the data so that the value of
MTF(O) = 1. The MTF of the whole imaging chain (focal spot to the viewing station)
is responsible for the spatial resolution limit of the system (Bushberg et al. 2002).
Two MTFs are shown in Figure 6.
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Figure 6. Two examples modulation transfer functions, one actual and the other
ideal, having perfect frequency response.
A cruder but quicker means of assessing spatial resolution is by imaging a bar
pattern phantom and then assessing the image for visibility of the various size bars.
A radiograph of a bar pattern phantom is shown in Figure 7.
Figure 7. Two radiographic images of a bar pattern phantom, the lower one showing
superior spatial resolution (The lnstitute for High Energy Physics 2005).
Noise is the random fluctuation in OD or brightness in an image, causing it to have a
grainy appearance. Noise resulting from the limited number of X-ray quanta
absorbed by the image receptor ís called quantum noise and can be affected by the
dose chosen for the examination (Martin, Sharp & Sutton 1999). The more X-ray
photons absorbed per image area, the lower the OD/brightness fluctuations due to
quantum noise. ln digital radiography, because an image is scaled prior to display, it
is not limited by contrast like a radiograph is. lt should instead be limited by noise,
meaning a good digital image should contain a tolerable amount of noise but not so
much that it is not diagnostically acceptable. This is called a quantum-limited system
(Aichinger et al. 2004). ln digital radiography, it is easier for operators to use higher
Âmorphars Sel¿nium ddector
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exposures than is necessary because due to pre-display scaling the image will still
have good contrast. Within limits it will actually appear superior because it contains
less noise (Martin, Sutton & Sharp 1999). The situation is different in film/screen
radiography where, due to the narrow dynamic range of film, a radiograph is contrast-
limited, whereby it will be too light or dark to be diagnostically acceptable if a small
dose range is exceeded. Therefore, the dose/image quality trade-off must have been
previously considered through the choice of film and screen used for the
examination.
The large area (macro) system transfer factor is a measure of the relationship
between the input to the imaging device, X-ray quanta, and the output 
- 
OD for film-
screen systems or monitor brightness for digital displays. ln digital systems, it is a
constant, where as in film-screen systems, which do not have a linear relationship
between dose and optical density it is a function of dose known as the film's gamma,
as shown in Figure B (AAPM Task Group #10 1998).
Figure 8. Typical responses of a CR plate and a film (AAPM Task Group #10 1998)
The total amount of image noise in a digital image is affected in part by the image
receptor's efficiency in transforming the absorbed energy into the next form of
information carrier (eg light or electrons) and electrical and quantisation noise or
graininess for film-screen systems. Spatial or temporal characteristics of noise
fluctuations can be described by the noise power spectrum 
- 
NPS( v ), also known as
the Wiener Spectrum (Aichinger et al. 2004).
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Whilst the parameters discussed above have the advantage of being objective they
do not provide an overall measure of image quality. Signal-to-noise ratio (SNR) may
be used as a comprehensive quality parameter in digital radiography because as a
result of post-acquisition image processing, the display of low contrast details is
limited only by noise. Theoretically, SNR should be at least 3-5, so that an image
detail can be recognised reliably by eye (Rose 1948). When considering quantum
noise (which has a Poisson distribution) the noise can be calculated from the number
of X-ray quanta per unit area, ie pixel, so:
o=^[ñ Equation 7
where o is the standard deviation (noise) and N the mean number of photons per
unit area. The SNR is therefore:
,sl/R=M= N:.,ÆOJN Equation I
Equation 9
number of photons absorbed 
- 
not
and so for a given beam quality, doubling the number of X-ray quanta (dose) will
result in an improvement of the SNR by a factor of Ji :1.4 .
The X-ray photons that build up the radiation image are partly absorbed by the image
receptor, with the probability of interaction being known as the quantum detection
efficiency (aO5.1.
QDE=W
is in reality governed by theBecause the SNR
incident:
sNR,"o,,,, = r[N0"r",^ = Equation 10
Detective quantum efficiency (DOE) is used as an indicator of how well an imaging
system transmits information from input to output. The DQE is defined as:
ODE.N ,ÙtcIaeilt
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DOE =(s¡/R""{
- '- (,s¡/Ri, )2
Because MTF( v ) describes how an imaging system processes
NPS(v ) describes the processing of noise, combining these gives:
,Sly'R2ou, 
-IMTF(v)1'zÀ/P^l(v)
Do^tu\ 
- 
KIMTF(v)1'z
li.NPS(rz)
The NPS(ru ) is the noise variance (o2 ) and is already a squared quantity. The
SNRin is the square root of the number of input quanta tJ¡¿l and so SNR2,. = ¡.
The DQE is therefore:
Equation 11
signal and the
Equation 12
Equation 13
where as discussed above, K is the image receptor's gamma. The DQE has become
the standard bywhich the performances of X-ray imaging systems are measured. ln
a perfect system, the DQE would be equalto the QDE; while in a system with perfect
noise properties only, the DQE(v=0) would be equal to the QDE (Bushberg et al.
2002).
2.7 IMAGE CAPTURE
2.7.1 Film-screen technoloqies
ln diagnostic radiology, there are two distinct means of obtaining images, film and
digital capture. The traditional film based method involves an emulsion-covered film
being sandwiched against an intensifying screen, within a cassette. The film and
intensifying screen are together called a film-screen combination. Some of the X-
rays striking the intensiñying screen (phosphor) are absorbed (photoelectric effect),
which results in the emission of fluorescent light photons.
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Figure 9. Emission of light (fluorescence) following photoelectric absorption in an
intensifying screen (Adcock 1 999).
A latent image made up of silver crystals is produced when the light ionises the
gelatinous silver bromide emulsion layer on the film, as shown in Figure 9. Upon
developing, the silver bromide is removed, leaving only the silver image on the film
acetate base. The film may be single or dual-emulsion, the former requiring one
intensifying screen and the latter two. Dual-emulsion systems have replaced single-
emulsion systems in almost all applications, except mammography. The main
benefit of the dual-emulsion/screen system is greater sensitivity, which allows for
lower patient doses; however, screen blur and parallax blur, caused by the physical
separation of the two emulsion layers by the film base, is greater. For this reason,
single-emulsion/screen systems are still routinely employed in mammography, where
very high spatial resolution is required (Bushberg etal.2002).
The number of photons used in the production of a radiographic image affects both
the image quality and the radiation dose. lf system speed is increased, by raising the
light output of the intensifying screen per absorbed X-ray photon, less photons are
used to form the image. The use of thicker intensifying screens can therefore reduce
dose; however, the resulting images are more blurry and noisy due to the increased
lateral diffusion of fluorescent photons. Photon fluence affects both signal magnitude
and fluctuations in background noise, giving a straight trade-off between dose and
image quality (Martin, Sutton & Sharp f 999).
Modern film-screen combinations use GdzO2S (rare-earth) phosphor screens, which
emit mainly green light. This type of phosphor has largely replaced the CaWOa
screens previously used, which emit mainly blue light. The film in use needs to be
sensitive to the light being emitted by the screen. The main reasons for the
replacement is that rare-earth screens have a lower K-edge (50.2 keV) than CaWO¿
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(69.5 keV). The K-edges are determined by the heaviest elements in the
compounds, Gd and Ca respectively. The mass-attenuation coefficients of the two
materials are similar up to 50 keV but as a result of the lower K-edge, rare-earth
screens have a higher mass-attenuation coefficient above 50 keV (Aichinger et al.
2004).
The factors which affect the quality of a radiograph include subject contrast 
- 
due to
patient heterogeneity, film contrast, screen/film blurring and radiographic mottle,
radiographic mottle being the fluctuation of the film's optical density around the mean
(Martin, Sutton & Sharp 1999). One of these factors may be affected by other
contributing factors, eg film processing, screen conversion efficiency, screen
absorption, film contrast, film speed, film granularity and quantum mottle all affect the
amount of radiographic mottle (Aichinger et al. 2004). The biggest disadvantage of
film-screen systems is their limited dynamic range which results in sub-optimal
visualisation of structures in projections with large differences in tissue absorption,
such as the chest (Schaefer-Prokop & Prokop 1997).
2.7.2 Diqital detectors and imaqe processinq
The main types of digital radiography detectors are computed radiography (CR),
which utilises photostimulable phosphor (PSP) plates, charge-coupled-devices
(CCD) and indirect and direct capture flat panel systems.
2.7.2.1 Computed Radiography
CR has been available for about 20 years. ln CR, X-rays incident on the europium
doped BaFBr and BaFl PSP plates excite electrons to a higher energy level, where
some are caught in meta-stable energy levels called F-centres. The intensities of the
incident X-rays are represented by the number of trapped electrons and the spatial
distribution of the X-rays by the F-centres. The PSP is read in a CR reader, where a
laser is used to release the electrons from their'trap'. As the electrons drop back to
lower energy valence bands, light is released, which is imaged by a light guide and
photomultiplier tube. lmage readout is by flying spot scanner, where luminescence is
stimulated one pixel at a time, which is why readout times of at least a minute exist.
The general process is shown in Figure 10. Pixel size is determined by the size of
the 'spot' scanned by the laser and is usually in the order of 100 - 200 microns for the
chest. A new development called parallel reading (line scanning) may speed the
digitisation process, where a linear laser light source stimulates a whole line of
'pixels'at once (Neitzel 2005).
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Figure 10. Computed radiography image capture and processing.
Considerable image post-processing is performed following digitisation. Because
only a part of the total dynamic range and the area of the PSP plate is used in each
exposure, signal normalisation and border detection are performed by histogram
analysis, in order that the brightness and contrast of the displayed image will be
acceptable. Un-sharp mask filtering is usually performed, where a low-frequency
pass filter is applied, to create a mask containing only low-frequency data. This
image is then subtracted from the initial image to produce a high pass filtered image
(containing high frequency information 
- 
mainly edges and noise), which is weighted
and added to the initial image. The exact format of the low-frequency pass filter
determines how un-sharp the mask image will be, and the weighting factor applied to
the high frequency 'edge enhanced' image, the degree of filtration. Due to still being
cassette based, CR is still usually the modality of choice for bedside chest
radiography (Schaefer-Prokop et al. 2003).
The most straightfonruard way to improve the absorption efficiency of a PSP plate is
to increase its thickness, however, the resulting greater lateral spreading of light, in
the thicker phosphor and of the laser light, impairs spatial resolution (Neitzel 2005).
Another is to make the PSP plate substrate transparent to the laser stimulated light
and collect it on both sides with a dual collection (readout) system. Dual-reading has
been suggested to increase dose efficiency by 30-40o/o, making it comparable to
digital radiographic systems (Schaefer-Prokop et al. 2003).
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Also available is dual-plate CR, where two CR plates are exposed together,
separately scanned to form a front and back image and then superimposed to form
an image. Using duel-plate CR, improved SNR (31-36%) and contrast-to-noise-ratio
(28-30o/o) have been shown for chest imaging without any increase in patient dose
(Liu & Shaw 2001).
2.7.2.2 Charge Coupled Devices
A CCD chip is essentially an integrated circuit made of crystalline silicon, with
discrete pixel electronics etched into its surface. They are commonly composed of
1024 X 1024 or 2048 X 2048 pixels (Bushberg et al. 2002). Also incorporated in the
detector is an intensifying screen, which emits fluorescence photons when struck by
X-rays, as shown in Figure 11. The silicon surface is photosensitive, meaning that as
light interacts with the pixel, electrons are liberated and build up in the pixel. A
voltage across the pixel keeps the electrons within that pixel until it is time to be read
out, at which time the electronic charge is shifted pixel by pixel by voltage control
onto a transistor, where it produces an electronic signal, which is then digitised.
Figure I l. Schematic of a CCD X-ray detector (Quid United Ltd 2006).
For small field-of-view (FOV) applications such as dental radiography, the
intensifying screen can be in close contact with the chip, resulting in very little lost
light. For large FOV applications such as chest radiography, it is impossible to focus
the light emitted from the screen onto one CCD chip without losing a very large
fraction of the photons (Bushberg et al. 2002). For 35 X 43cm chest radiography
using a 30 mm CCD chip, the demagnification factor is 167:1, meaning even using
perfect lenses, light loss is about 99.7Yo. lf an insufficient number of quanta (light
photons) are used to construct the image after the initial X-ray detection stage, a
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secondary quantum sink will occur, where the pixel signal to noise ratio becomes
less than the square root of the number of quanta per pixel. Any X-ray system with a
secondary quantum sink will have image quality that is not commensurate with the
necessary dose (Bushberg et al.2002). For this reason, large FOV CCD detectors
use an array of CCD chips to improve efficiency.
2.7.2.3 Flat Panel Detectors
ln indirect detection flat panel detectors, a columnar caesium iodide (Csl) or rare
earth intensifying screen is used in conjunction with a hydrogenated amorphous
silicon flat panel detector, consisting of a large number of individual detector
elements. Each element contains a light sensitive region (photodetector) and a
transistor, and so is capable of storing charge when stimulated by light and then
releasing it to form an electrical signal, as shown in Figure 12. X-rays are incident
upon the phosphor from the front, while the emitted light photons emanating from the
back of the phosphor are imaged by a hydrogenous amorphous silicon/thin-film
transistor technology (TFT) layer (Bushberg et al.2002\.
The Csl scintillator is of a small, column-like crystal structure that minimises lateral
diffusion of the emitted light, resulting in excellent spatial resolution (Hoheisel & Batz
2001). A thick phosphor layer with correspondingly high QDE is therefore possible.
Commercially available Gd2O2S screens may be used as an alternative but must be
kept thin to achieve the same MTF and consequently the DQE suffers (Neitzel 2005).
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Figure 12. Schematic of an indirect detection flat panel (Ewert 2002).
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Direct flat panel detectors are made from a layer of photoconductor material on top of
a TFT array. The photoconductor is usually selenium, which has many of the same
properties as silicon but with a higher atomic number. With a relatively low atomic
number (34), selenium is not ideal as an X-ray absorption material (Neitzel 2005).
Other photoconductors such as lead oxide, lead iodide and mercury iodide offer
better photon absorption but are still being developed. Rather than light, electron
hole pairs are the information carriers, which travel through the selenium matrix
under the influence of an electric field and are collected at the TFT array. ln the
image receptors based on amorphous selenium technology, the absorbed X-ray
energy is directly converted to an electrical signal (direct digital detectors). By
avoiding the intermediate light stage (and associated lateral diffusion), the system
offers the potential for increased spatial resolution and is typically limited only by the
dimensions of the detector element. The fact that electrons can be made to travel
with a high degree of directionality, due to application of the electric field, results in
minimal blurring of the resultant image (Bushberg el a|.2002).
Flat panel detectors have a fixed pixel size due to the readout array, generally in the
range of 100 - 200 ¡rm, which equates to limiting spatial resolutions of 2.5-5 lp/mm.
Pixel sizes much smaller than this are not possible at the time of writing because of
the inability to produce small enough electronics. So, with a limitation on electronic
component size, a further reduction of pixel size affects the fill-factor (proportion of
sensitive area to electronics) and consequently the DQE (Neitzel 2005).
ln a 'perfect detector', the DQE would be equal to the QDE 
- 
a quantum limited
system 
- 
and the only way to improve the SNR would be to increase the number of
photons striking the image receptor or use a thicker or alternate detector material
(Aichinger et al. 2004). Numerous authors have shown that flat panel detectors have
a significantly higher DQE than CR systems (Rong et al. 2001). Neitzel measured
the MTF and DQE for direct and indirect flat panel detectors and CR plates according
to the standard IEC 62220-1 and found the following: For MTF, the direct flat panel
was superior to the indirect flat panel, which in turn was superior to the CR system.
With respect to DQE, the indirect flat panel was superior to the direct flat panel,
which in turn was superior to the CR system (Neitzel 2005).
One of the main advantages of digital systems over film-screen systems is that the
dose-response curves of digital detectors are linear over a broad exposure range,
meaning variations in exposure are better tolerated. This, combined with post-
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processing algorithms, means images are often better and retake rates lower
(Carrino 2003).
All receptor materials have a particular energy response, resulting from the physical
characteristics of the receptor, eg photoelectric cross-section and (effective) atomic
number. ln other words, the detector efficiency (DOE) varies with the beam quality
incident upon it; which in practice, if not allowed for, results in under- or over-
exposure at particular tube voltages. AEC systems therefore need to be adjusted to
compensate for the tube voltage selected, which is achieved through the application
of a calibration factor for each possible tube voltage selection. This is on top of the
energy correction factor for the AEC itself (Aichinger et al. 2004).
2.8 ASSESSMENT OF IMAGE QUALITY
Techniques for measuring image quality can be separated into two categories 
-
those involving the assessment of test objects and those involving assessment of
clinical images. lncorporating a test object in a tissue equivalent phantom can
simulate imaging a patient, although assessments of clinical images should also be
performed to ensure their adequacy for diagnosis. A full evaluation of image
performance may be gained from trials in which clinical outcomes of cases are
examined; however, such undertakings are lengthy and may not provide the
necessary results within a feasible time frame (Martin, Sharp & Sutton 1999).
ln film-screen radiography the image may be assumed to be optimal if the optical
density is correct, but this is not the case for digital imaging. The contrast and
brightness of the displayed image can be adjusted post-acquisition to give the correct
range for viewing for a wide range of doses. Whilst it may be tempting to optimise
image quality/dose through similar means as film-screen systems, optimal results will
not be obtained, as the levels to which exposures can be reduced before quantum
mottle (noise) becomes a problem have to be set for individual examinations (Martin,
Sutton & Sharp 1999).
Threshold contrast may be measured by observers viewing an arcay of equally sized
discs of varying contrast for visibility of the lowest contrast disc. lf a test object is
used in which target contrast and size is varied, a contrast-detail diagram can be
developed. This is a plot of the minimum detectable contrast for an image feature as
a function of size (diameter). Noise effects can result in random fluctuations in
visibility, and therefore results (Martin, Sharp & Sutton 1999). Test objects that
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employ metal discs and bars to provide objects of varying size and contrast cannot
be used on their own to assess the changes in radiation quality on clinical images,
because attenuation in tissue changes quite differently with photon energy than in
metals, ie different energy dependencies (Martin, Sharp & Sutton 1999). (Vano et al.
1995) found a good correlation between image quality results of contrast detail test
objects used in conjunction with a PEP and those based on the assessment of
clinical images. Previous studies have shown that there is no significant difference in
observer response between radiologists and non-radiologists in contrast-detail
studies, suggesting radiologists are not needed as observers (Rong et al. 2001).
One particular contrast-detail phantom is the CDRAD phantom, which is frequently
used to subjectively evaluate contrast-detail response. The CDRAD phantom aims
to take some of the subjectiveness out of the scoring process by having the targets in
random corners of quadrants, whereby observers must have chosen the correct
corner of the quadrant in their observation of targets for them to count.
Christodoulou et al found that when used in conjunction with the CDRAD Analyser
software, the potential exists for it to be used as a quantitative image quality analysis
tool (Christodoulou et al. 2006). ln comparing the software with human observer
performance, Pascoal et al found the relative performances to agree, but not the
absolute performances (A Pascoal et al. 2005). ln view of this, image scores
acquired with the software can be freely compared, but not with image scores where
human observers were used. The authors found the software precision to be very
good and the software to be a valid approach to objective image quality comparisons.
One subjective means of assessing image quality is to obtain a number of images of
test objects or patients and rate them relative to each other. ln this way, images
produced at different doses can be ranked for quality. Whilst still subjective, by
repeating the experiment with different observers and images, reasonable agreement
can be attained. However, the method still does not answer the questions: (1)
whether a lower dose would still provide images of sufficient quality and (2) whether
the best image is actually acceptable for the diagnostic purpose (Martin, Sharp &
Sutton 1999).
The method of constant stimulus (MCS) tries to take the random noise fluctuations
into account by using a test object in which the contrast is variable. The observer is
shown a set of images containing the signal at contrasts varying from the signal
being easily visible to not visible. By obtaining several images at each contrast level
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and for each, recording the number of occasions the signal is seen, the true positive
response is found. The visual response curve can be obtained by plotting true
positive response against contrast. The threshold contrast is usually taken as that
which produces a50o/o visual response (Martin, Sharp & Sutton 1999). The methods
discussed so far assume an intrinsic perceptual threshold that must be exceeded
before a signal is deemed visible; however, this has been challenged on the basis of
the observer being capable of varying his visual threshold based on the confidence
required (Martin, Sharp & Sutton 1999).
Another method of assessing image quality is the receiver operating characteristic
(ROC) curve, in which an observer assesses a number of images, only some of
which contain abnormality. The observer identifies the image as either normal or
abnormal, which can result in true positive, true negative, false positive and false
negative responses. The decision threshold can be varied, which will affect the
number of positive responses. The results are plotted as either sensitivity against
specificity (probability of correct negative diagnosis) or equivalently, as true positive
responses againstfalse positive responses (Figure 13). This is what is referred to as
the ROC curve, with the position of the curve relative to the axes representing the
image quality. The closer the curve is to the top left-hand corner of the graph, the
better the image quality (The lnternational Commission on Radiation Units and
Measurements 1996).
Figure 13. Two ROC curves, the red one better than the black, being closer to the
ideal- 100% sensitivity and 0% specificity, as marked with the asterisk (Halls 2003).
For a quantitative measure of image quality, the area under the ROC curve may be
calculated. While such techniques measure the discriminability between signal and
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noise, they do not provide the physically meaningful measure provided with the
contrast-detail curves and constant stimulus methods. ln addition, the ROC curve
displays the trade-off between sensitivity and specificity, or between true positives
and false positives, for a spec/ic set of imaging conditions, meaning it is not
appropriate for the initial stages of dose/image quality optimisation of imaging system
assessment (Martin, Sharp & Sutton 1999).
Forced choice methods may also be used, in which the observer provides relative
(rating) responses for two or more images, of which only one contains a signal.
Forced choice experiments may be used to obtain the area under the ROC curve or
to produce contrast-detail diagrams (Martin, Sharp & Sutton 1999).
Other issues that must be considered are the pixel size chosen for the application,
image post-processing to be applied and choice of display screen. lf the display
device is not capable of displaying all of the image details, or too large a pixel size is
chosen, some details may not be visible and the value of the examination may be
jeopardised.
Guidelines on image quality have been developed by the Commission of the
European Communities (CEC), which specifies diagnostic requirements for a
radiograph of a normal (disease free) child for common examinations. An equivalent
report exists for adult radiology. The criteria include anatomical structures that
should be visible and features which should appear sharp. A 'diagnostically
acceptable' radiograph would usually fulfil about 90% of the image quality criteria
(European Commission 1996b). The guidelines encompass patient positioning,
radiographic technique and imaging performance. lf used for assessment of image
quality, at least two radiologists, working independently, score at least 10
radiographs against the criteria; the average of which is then quoted. All viewing
conditions should be standardised and the radiologists should have a reference set
of ideal'images to compare the radiographs with (Martin, Sharp & Sutton 1999).
This methodology has limitations, including being based on normal anatomy, which
may be less demanding for interpretation than abnormal anatomy and the potential
exists for variations in observer acceptability thresholds. Despite its limitations,
Martin et al believe it to be the best method that is available for assessing the quality
of radiographs ín individual departments (Martin, Sharp & Sutton 1999). As well as
the image quality criteria, the guidelines also indicate the size of particular image
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details that should be resolvable, examples of good radiographic technique and
reference entrance surface doses.
2.9 STUDIES COMPARING DOSE AND IMAGE QUALITY FOR DIFFERENT X.
RAY SYSTEMS
As a result of the possibility for post processing and display options, digital
radiography offers the possibility of dose reductions (Martin, Sutton & Sharp 1999).
Van Heesewijk et al found that the diagnostic quality of chest radiographs obtained
using selenium detectors is the same as with screen-film systems with only 35% of
the dose (van Heesewijk HP et al. 1996). Schaefer-Prokop et al used a contrast
detail phantom to show that storage phosphor plates need on average 1.7 to 2.7
times more dose than selenium to achieve equivalent detail visibility (Schaefer-
Prokop & Prokop 1997). The authors suggest that contrast resolution, rather that
spatial resolution, is probably the limiting factor in digital radiography.
ln a contrast-detail study using the CDRAD phantom, in which adult chest
radiography using screen/film, CR and flat panel systems were compared, Rong et al
found that the flat panel system had significantly better low-contrast performance
than SF or CR systems (Rong et a|.2001). lt was estimated that dose savings of
70%-90o/o could be achieved at equivalent low-contrast performance. ln a similar
study, also using the CDRAD phantom, Fischbach et al found that an indirect flat-
panel system provided equivalent results compared with CR with respect to high
frequency information and superior results for low contrast details (Fischbach et al.
2002). The authors found that using the image quality parameter lQF, the image
quality was equivalent for the two systems at a entrance dose saving of B7o/o for the
flat panel system. A ROC-analysis of clinical images confirmed the CDRAD phantom
results.
ln a study comparing single- and dual-readout CR and a DR system, using an
anthropomorphic chest phantom and templates to simulate various lung lesions,
Uffmann et al found a significant difference in performance between the single-
readout CR and the dual-readout CR and DR systems (Uffmann et al. 2005). The
performance of the dual-readout CR and the DR systems were similar. ln a clinical
preference study, Gruber et al found that a Philips indirect DR system was superior
to a Fuji CR system when both were used with the same dose (Gruber et al. 2006).
The performance of dual-readout CR system was similar (no significant difference) to
the DR flat panel system when the DR image was obtained with 50% less dose.
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Monnin et alfound that a dual-readout system offered potential dose reductions over
a single-readout system in paediatric radiology (Monnin et al. 2006). This was a
result of a higher DQE and lower relative noise allowing the dual-readout system to
be used at higher sensitivity AEC settings.
Pascoal et al compared the image quality and effective doses for an indirect DR
system, CR system and CCD system for chest radiography. The indirect DR system
performed best overall, followed by the CCD and then the CR system (A. Pascoal et
al. 2005). Monnin et al tested the imaging performance of a CR system, selenium
flat panel and 400-speed film-screen system, used for conventional radiography, at
four standard radiation qualities. Except for one beam quality, the film-screen system
required a lower exposure than either digital system (Monnin et al. 2005). The
authors also found that the standard practice of raising beam energy when switching
from film-screen to CR systems, to improve the dose/image quality balance, is not
appropriate when switching from film-screen to selenium-based DR systems.
ln an image quality and dose comparison of silicon and selenium flat panel detectors,
Bacher et al found the silicon system had superior low contrast performance at a
lower dose than the selenium system, for both posteroanterior and lateral views
(Bacher et al. 2006).
2.10 SUMMARY AND HYPOTHESIS
It is evident that in adult radiology, indirect flat-panel DR systems are superior to
single-readout CR systems. The aim of this work is to determine whether the same
is the case in paediatric radiography, with its quite different radiographic techniques,
beam qualities, scatter conditions and patient dose considerations.
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3. Materials and Methods
The radiology department at the Princess Margaret Hospital (PMH) for Children in
Perth, Western Australia was replacing the computed radiographic equipment in its
two general X-ray rooms with indirect capture digital systems. lts aim in this process
was to increase patient throughput without the need for an additional general X-ray
room. lmage quality and radiation dose were obviously important considerations for
the department. This allowed the opportunity of comparing image quality and patient
radiation dose between the outgoing CR equipment with its replacement DR
equipment.
Three experiments were performed, the first was an image quality comparison of the
two systems under standard conditions; the second the same experiment but under
clinical conditions. The third experiment was a dose comparison with image quality
held constant.
3.1 X.RAY EQUIPMENT
The outgoing X-ray equipment was two identical computed radiographic (CR)
systems that had been routinely used in the hospital for many years, one of which
was used for all experiments in this study. The X-ray generator was a Philips
Optimus B0 and the X-ray tube a Philips SRO 33100 with 0.6 and 1.2 mm nominal
focal spots. The total, fixed beam filtration was equivalent to 2.5 mm aluminium. The
grid used had a ratio of 8:1,36 lines/cm and focal distance of 100cm. The CR
system consisted of Agfa MD40 35cm x 43cm photostimulable phosphor plates
(PSPs) and an Agfa ADC Compact Plus single-readout digitiser, producing a 2320 x
2826 pixel matrix, with a pitch (pixel size) of 166 pm.
The replacement system was an indirect-capture flat panel digital radiography (DR)
system. The X-ray generator was a Philips Optimus 65 and the X-ray tube
specifications were identical to the CR system. The grid had a ratio of 12:1, 36
lines/cm and focal distance of 11Ocm. The detector was a Trixell indirect capture flat
panel with a Csl phosphor layer and an amorphous silicon/thin film transistor
photodiode detector array. lt produces a 2048 x2048 pixel matrix with a pitch of 200
prm, for an active imaging area of 410 mm x 410 mm.
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Both systems had been recently certified as compliant under Western Australia's
mandatory compliance testing program and had therefore passed standard
performance and radiation safety tests.
3.2 CONTRAST DETAIL PHANTOM
The phantom used in this study was a CDRAD 2.0 conventional/digital contrast-detail
phantom made by NuclearAssociates (Figure 14 and Figure 15). The phantom is a
26.5cm x 26.5cm x 1cm perspex tablet containing a 15 x 15 array of 1.5cm x 1.5cm
quadrants with a hole drilled at the centre of each. The holes gradually increase in
depth along the X dimension, and increase in diameter along the Y dimension. This
results in subtly changing image contrast and detail size. For quadrants containing
holes of 4 mm diameter and smaller, an additional identical hole is drilled in a random
corner, which serves to reduce false detection resulting from a priori knowledge of
object location, when scored by human observers. The depth and diameter of the
holes vary from 0.3-8.0 mm (milling tolerance of 0.02 mm) in 15 steps, increasing
approximately logarithm ically.
Figure 14. Photo of the CDRAD phantom.
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Figure 15. Radiograph of the CDRAD phantom.
3.3 PATIENT SIMULATION
ln order to simulate paediatric abdomens of varying age and size, 30cm x 30cm x
2.5cm slabs of poly methacrylate (PMMA) were used. An adult abdomen is often
simulated using a 20cm thick slab of Perspex and so, to simulate the paediatric
abdomen in this work, three different thicknesses - 6, 11 and 16cm 
- 
were used to
represent patients of varying (arbitrary) age. These thicknesses were achieved using
PMMA slabs plus the 1cm thick CDRAD phantom. For each image acquisition, the
CDRAD phantom was placed in the middle of the stack of PMMA slabs, as
recommended by the manufacturer.
3.4 IMAGE CAPTURE AND PROCESSING
The radiographic techniques for imaging the three phantoms on both X-ray systems
were recommended by a PMH paediatric radiographer as being typical of clinical
practice and confirmed by a second radiographer. For both systems, the clinicaltube
voltages used were as recommended by the manufacturers. The instances where
the actual techniques differed from those suggested were (1) the X-raytubes'small
focal spot were always used to maximise image sharpness and (2) for one of the
experiments, the X-ray beam filtration used was as suggested in the European
Commission guidelines for paediatric radiography, rather than as used clinically at
PMH (European Commission 1996b). The tube voltage used clinically differed
between the CR and DR systems. The different energy responses of the PSP plate
and Csl phosphor meant that different X-ray beam energies were required to
maximise the detectors' quantum detection efficiency.
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For each acquisition, the X-ray beam was collimated to be between the edge of the
CDRAD phantom and the edge of the quadrant pattern on all four sides. ln this way,
the field size was always the same and the scatter conditions were changed only by
phantom volume.
3.4.1 lmaqe Qualitv Comparision Under Standard Conditions
ln order to compare the image quality of the two systems under standard conditions,
images were acquired on both systems with the same beam filtration and phantom
entrance exposure. The additional beam filtration used was 1 mm Al and 0.2 mm
Cu, as recommended in European Guidelines on Quality Criteria for Diagnostic
Radiographic lmages in Paediatrics (European Commission 1996b). For the CR
system, the unit's AEC could only be used if the grid was in place. According to the
PMH radiographers, the grid 
- 
and consequently the AEC 
- 
was only used for large
patients (16cm phantom). Therefore, for the largest phantom size, the AEC was
used to terminate the exposures at the optimal mAs. For the other two phantom
sizes the 'optimised' exposure to be used was determined by trial and error to
achieve the accepted target exposure index (LgM) of 2.1. LgM is a parameter
specific to Agfa that is displayed automatically with each image. lt represents the log
of the mean pixel value of the raw image data and is a surrogate of log(exposure)
(Schaetzing 2004). lmages were then acquired on each system with exposures
(mAs values) corresponding to half and double the optimised values.
ln order to minimise noise effects in image scoring, six replicate images were
acquired for each of the imaging conditions investigated. The only differences in
radiographic technique between the CR and DR were slight differences in tube
voltage, for the reasons discussed above, and source-image-distance, to suit the grid
focal lengths,
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Table l. Radiographic techniques used for the optimised image acquisitions on the
CR system for the comparison under standard conditions.
to the inherent tube filtration which was equivalent to 2.5 mm Al
Table 2. Radiographic techniques used for the optimised image acquisitions on the
DR system for the comparison under standard conditions.
CR digitisatíon of the PSPs using the Agfa ADC Compact Plus unit was performed
and the standard abdomen image processing used with an exposure class of 400.
'Study groups'chosen for digitisation of the 6, 11 and 16cm phantoms were 18
months 
- 
5 years, 6 
- 
12 years and 13 
- 
16 years respectively. For the DR system,
the'child abdomen' protocol was chosen and small, medium and large child size for
the 6, 11 and 16cm phantoms respectively. All images were exported to the
hospital's Agfa IMPAX picture archiving and communication system (PACS) so they
could be retrieved for analysis at a later stage.
3.4.2 lmaqe Qualitv Comparision Under Clinical Conditions
Because the additional tube filtration used at PMH for both CR and DR differed from
that recommended in the European Commission guidelines, the experíment
described above was repeated using the filtration employed clinically at PMH.
Different beam filtration was employed for CR and DR, so using the same doses for
PEP Tube Voltage Focal Additional Grid AEC Exposure SID Speed
Thickness (kV) Spot Filtration* in Used (mAs) (cm) Gtass
(cm) Place
6 58 Small 1 mm Al + No No 1.6 100 400
(0.6 mm) 0.2 mm Cu
11 62 Small 1 mm Al + No No 2 100 400
(0.6 mm) 0.2 mm Cu
16 70 Small 1 mm Al + Yes Yes 13.4 100 400
(0.6 mm) 0.2 mm Cu
PEP Tube Voltage Focal Additional Grid AEC Exposure SID Speed
Thickness (kV) Spot Filtration* in Used (mAs) (cm) Glass
(cm) Size
6 63 Small 1 mm Al + No No 1.6 110
(0.6 mm) 0.2 mm Cu
11 70 Small 1 mm Al + No No 1.6 110 N/A
(0.6 mm) 0.2 mm Cu
16 81 Small 1 mm Al + Yes No 10 110 N/A
(0.6 mm) 0.2 mm Cu
. Additional to the ¡nherent tube filtration which was equivalent to 2.5 mm AI
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the DR system as used for the CR system was not appropriate for this experiment.
For this reason the DR exposure (mAs) was optimised independently of the CR. The
DR system's AEC can be used with the grid in or out and so was used for the
acquisition of all images. The radiographic techniques employed are given in tables
three and four.
Table 3. Radiographic techniques used for the optimised image acquisitions on the
CR system for the comparison under clinical conditions.
Table 4. Radiographic techniques used for the optimised image acquisitions on the
DR system for the comparison under clinical conditions.
3.4.3 Dose Comparison Under Standard Conditions
ln order to assess the patient dose performance of the two systems, an experiment
was conducted where the image quality of both systems was held constant and the
doses measured. The experiment was performed similarly to the previous two and
under standard conditions, ie with the 1 mm Al and 0.2 mm Cu additional beam
filtration.
PEP Tube Voltage Focal Additional Grid AEC Exposure SID Speed
Thickness (kV) Spot Filtration* ¡n Used (mAs) (cm) Glass
(cm) Size
6 58 Small Nil No No 1.25 100 400
(0.6 mm)
11 62 Small Nil No No 2 100 400
(0.6 mm)
16 70 Small 0.05 mm Yes Yes 11.4 100 400
(0.6 mm) Hf
. Additional to the inherent filtration which was equivalent to 2.5 mm Al
PEP Tube Voltage Focal Additional Grid AEC Exposure SID Speed
Thickness (kV) Spot Filtration* in Used (mAs) (cm) Class
(cm) Size Place
6 63 Smalt 2 mm Al No Yes .89 110 N/A
(0.6 mm)
11 70 Small 2 mm Al No Yes 1.2 110 N/A
(0.6 mm)
16 81 Small 1 mm Al + Yes Yes 6.4 110 N/A
(0.6 mm) 0.2 mm Cu
. Add¡tional to the inherent f¡ltration wh¡ch was equivalent to 2.5 mm Al
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lmage quality is not an easy parameter to quantify and hold constant between
systems. ln this work, the IQF¡"" (image quality figure) specific to the CDRAD
Analyser software was used. The IQF is a simple measure that is automatically
displayed along with the contrast-detail curves. lt suggests the overall image quality
(by magnitude) of an image or group of images, based on the total number of targets
detected. The lower the value is the better the image quality. The inverse metric
(lQFinu) is exactly that, where the higher the value is the better the image quality
(Artinis Medical Systems BV 2006). lmages were acquired on the DR system at
numerous exposure levels (mAs values) until a IQF¡nu value was reached that
matched the IQF¡nu value for the optimised CR images. The doses at this
comparable image quality were then compared.
3.5 DOSIMETRY
Patient doses were estimated by measuring entrance su¡face exposures (ESEs) and
then converting them to effective doses using the dose calculation software package
PCXMC 1.5, which uses tables of data computed with Monte Carlo techniques
(Tapiovaara, Lakkisto & Servomaa 1997). ESEs were measured using a Victoreen
660 electrometer and Victoreen 660-44 ionisation chamber, both with current
calibration certificates. ln order to obtain true ESE measurements, ie without
backscatter, and to prevent the ion chamber from affecting AEC chamber
performance and/or phantom target detection, ESE measurements were performed
separately from the image acquisition exposures. ldentical techniques were used
and the reproducibility of both uníts' exposure factors and output were first confirmed
with a calibrated NERO 8000 mAx non-invasive X-ray beam analyser. All
parameters were reproducible to within 5o/o. For ESE measurement, the ion chamber
was placed in line with the X-ray tube's central axis to minimise the impact of the heel
effect. ESEs were measured three times for each projection and the mean of the
readings taken as the ESE. Where necessary, the values were corrected using the
inverse square law to the phantom entrance surface.
Effective doses were calculated by inputting each ESE into the software package
PCXMC 1.5, along with the radiographic projection specifics, tube voltage and beam
filtration. The effective doses are displayed in the graph legends in the result
sections of chapters four, five and six. The effective dose calculations for each can
be found in appendix 1.
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3.6 IMAGE SCORING AND DATA ANALYSIS
The images were retrieved from the hospital's PACS and imported into the CDRAD
Analyser software for analysis. Computer analysis was chosen because it provided
results that were objective, reproducible and it was far less labour and equipment
intensive than manual-scoring with human observers.
A CDRAD Analyser file was created for each comparison being made and the
analysis performed. Each analyser file contained two 'groups' (CR and DR), with
each containing the six replicate images for comparison. The detection significance
level (alpha) used was 1 x 10-1a. This differed from the software default of I x 10-8,
which produced noisy curves that would not have presented well to clinicians. The
software requires entry of the SID to aid in target detection, but only one SID can be
entered per analysis. Because the CR and DR images were acquired at slightly
different SlDs 
- 
100cm and 1 1Ocm respectively 
- 
the SID was entered as 105cm. lt
was first confirmed that this Scm discrepancy in SID did not result in any difference in
target detection on either system. The software allows the user to select a particular
image and see its contrast-detail curve and IQF¡nu value; or select a group containing
the six replicate images to see the group's combined curve and IQF¡nu value; or select
'project total' to see the same for all groups in the project, eg CR verses DR under
one set of conditions. lt is the 'project total' outputs that are shown in the result
sections of chapters four, five and six.
As an example of how to interpret the contrast-detail curves, figure 17 shows one CR
and one DR curve where there is a clear case of differing image quality between the
two systems. Both curves were produced by the CDRAD Analyser software based
on six replicate images acquired with each system under standard conditions. The
DR curve is quite noticeably closer to the bottom-left of the graph than the CR curve.
This means that more of the phantom targets were detected and therefore the image
quality of the DR system is superior to that of the CR system under that specific set
of conditions. The further the two curves are apart, the greater the difference in the
number of targets detected and therefore, imaging performance. The top-left part of
the curves correspond to the largest, lowest contrast targets detectible in the CDRAD
phantom and the bottom-right of the curyes the smallest, highest contrast targets.
This allows a display of the threshold contrast detectible for a range of target sizes 
-
in the form of a curve 
- 
and so both the low-contrast (top-left) and spatial (bottom-
right) resolutions of two systems can be compared at once. A perfect imaging
system would produce a curve that exactly followed the graph axes, ie where all the
I
i.
i
I
I
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targets were detectible. lt can be seen in Figure 18 that the difference in curve
positions is greatest at the top-left and least so at the bottom-right. This suggests
that whllst the DR system is superior across the range of target contrasts and sizes,
the greatest difference in the two systems is in their low-contrast resolutions.
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Figure 16. Example of a graph showing CR and DR contrast-detail curves generated
by the CDRAD Analyser software.
The lQFinu figure also suggests that the DR image quality is superior, showing an
IQF¡nu of 1.9 compared to the CR system's 1.3.
ln some cases the curves' proximity to each other and/or non-smooth appearance
affects the reliability of simple visual discrimination. ln such cases one may try to
look at the general curve positions to try and determine which system is superior,
although this is clearly not ideal. Furthermore, the CDRAD Analyser software's rigid
output does not provide a measure of the uncertainty of the results or the significance
of the difference between contrast-detail curves. To overcome these limitations, a
process was developed to measure the significance of the difference between CR
and DR. Due to the inflexible software outputs, the underlying data used to generate
the contrastdetail curves was used, this being how many holes were detected for
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each depth/diameter. This information is easily exported from the CDRAD software
as a text file. The CR group data for the 6cm phantom under standard conditions
with half the optimised dose (figure 16) is displayed inTable 5. This is the combined
data from 6 replicate images, together making up one group and is the raw data from
which the software produces the contrast-detail curves. Where targets were
detected in none of the six replicate images the value displayed is 0; where they
were detected in all six replicate images, the value displayed is 6. lt may be useful to
cross-reference Table 5. against the images of the CDRAD phantom itself (figures 14
and 15) to properly understand the data displayed. The probability of a target being
detected is the value displayed in divided by the number of replicate images (6).
Table 5. Aggregate number of targets detected for the CR group of six replicate
images.
ln terms of the overall system image quality it is the 'transition area' where the
probability of detection goes from 0 to 1 that is of most interest (and this is the region
through which the CDRAD Analyser software draws the contrast detail curve).
Regions where nothing is detected or all holes are detected are not so interesting. ln
those areas the probability of detecting a hole is 0 and 1 respectively.
Diam
(mm)
Hole Depth (mm)
0.3 0.4 0.5 0.6 0.8 I 1.3 1.6 2 2.5 3.2 4 5 6.3 8
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lnformation theory says that the amount of information present in such a probability
field is:
-ln roen Equation 14
So, where p = 0 or 1, log p = 0 and there is no information. Thus it is reasonable to
exclude these regions from analysis.
The following simple algorithm was used to perform this process:
o Start at the bottom left of the matrix where zero holes are detected
o Look at the cells above and to the right of the current one
o lf both are zero then remove the current cell, if not leave it in
. Go through all the 0 cells in this fashíon
o Then start at the top right of the matrix, where 6 holes are detected
. Look at the cells to the left and below the current cell
o lf both are 6 then remove the current one, if not leave it in
. Go through all the 6 cells in this fashion
This algorithm works well, except for where at one depth no holes are detected but
then some are found at a shallower depth. ln such cases it is more appropriate not
to remove the '0' values.
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Table 6. CR system transition data following application of the exclusion algorithm.
Diam
(mm)
Hole Depth (mm)
0.3 0.4 0.5 0.6 0.8 1.0 1.3 1.6 2.0 2.5 3.2 4.0 5.0 6.3 8.0
8.0
6.3
5.0
4.0
3.2
2.5
2.0
1.6
1.3
1.0
0.8
0.6
0.5
0.4
0.3
001356
000666
0001456
3004266
0015246
021546
002246
0001366
010144656
000'1 34666
02113666
0001000
0
Table 7. Corresponding DR system transition data post algorithm application.
Diam
(mm)
Hole Depth (mm)
0.3 0.4 0.5 0.6 0.8 1 1.3 1.6 2 2.5 3.2 4 5 6.3 8
8.0
6.3
5.0
4.0
3.2
2.5
2.0
1.6
1.3
1.0
0.8
0.6
0.5
0.4
0.3
0200216
0010126
00000236
400013356
030153266
003400046
2000103466
01000020556
010000112356
000000113666
00001034
0000010
000
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ln order to determine whether the two systems were significantly different, the target
detection frequencies were compared using a chi-square test, the null hypothesis
being that the frequencies of target detection with different hole depths was the same
for both CR and DR systems. The significance level used was 0.05. For a chi-
square test it is a general rule that no expected frequency should be less than 5,
however, Zar notes that it is tolerable to have a few frequencies smaller than this
value (Zar 1999). Combining depths in groups was necessary in order to avoid
having too many elements below the minimum frequency of 5. The following table
compares the detection results for the CR system (table 6) and DR system (table 7).
Table 8. Frequencies of target detection for corresponding CR and DR groups of
images.
The chi-square results are as follows:
chi-square 29.16
degrees of freedom 6
p< 0.00005663
From this highly significant chi-square value, one can conclude that target detection
in the CR and DR groups are significantly different. From the knowledge of the curve
positions it is the DR system that is superior.
Following the same procedure for the 1 1cm optimised-dose case under standard
conditions (figure 19), the chi-square results are as follows:
chi-square 9.22
degrees offreedom 6
p< o.16182427
ln this instance there is no significant difference in CR/DR target detection
frequencies and therefore difference in the performance of the two systems is not
significant. These results correspond with what one would expect from a visual
comparison of the curves in figures 17 and 19.
Hole Depths
(mm)
CR
DR
0.3 
- 
0.5
4
17
0.6 
- 
0.8 1.0 
- 
1.3
43 65
15 37
1.6 
- 
2.0 2.5 
- 
3.2
40n
45 27
4.0 
- 
5.0 6.3 
- 
8.0
1)12
16 20
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4. lmage Quality Gomparison of GR and DR under Standard
Gonditions
4.1 RESULTS
This section contains the CR and DR contrast-detail curves for the three phantom
sizes, each imaged at three dose levels under standard conditions. Please refer to
Section 3.6 for information about the production and interpretation of the graphs.
The same doses were used for both CR and DR and were dependent on the
optimised CR doses, as discussed in Section 3.4.1.
4.1.1 6cm Phantom
Figures 16, 17 and 18 show the contrast-detail curves for the 6cm phantom under
standard conditions at the optimised dose, half and double that dose, respectively,
together with the probability of the chi-square statistic for target detection frequencies
between the CR and DR systems. CR curves are those with data points.
Figure 17. CR and DR image
the optimised CR dose level.
doses are shown in the legend.
Chi-square p < 0.019
AIÞ}E = 1d4, a trb df of fìm = 0ì
6
E,
Ye
õ¿
1
1
1
.t
t,
0.3 04 0.5 0.6 0.8 1.0 1.3 1.6 2.0 2.5 3.2 40 5.0 6 3 8.0
ryh(m)
Group lQFlnv scores
AlptE = 1e-O14 å ødi dfotrlæ = q
ast
AlÞlE = 1e414 a øidi diñofffi =
2
I
\!
1
1
1
0
0.3 0.4 05 0.6 0.8 1.0 1.3 1.6 20 25 3.2 40 5.0 6.3 8.0
DeÉh (m)
Group lQFlnv scores
AlplE 
= 1e{14 å qidi dff of ffi = 0l
Figure 18. CR and DR image quality at
half the optimised CR dose level.
Effective doses are shown in the legend.
Chi-square p < 0.000057
quality at
Effective
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0.3 0.,a 0.5 0.6 0.E 1.0 1.3 1.8 20 25 32,t 0 5.0 6.3 8.0
OeÉh(nrf
Group lQFlnv scores
AryE - i€û4 a Fiqi dldl'Et - q
Figure 19. CR and DR image quality at
double the optimised CR dose level.
Effective doses are shown.
Ghi-square p < 0.16
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4.1.2 11cm Phantom
Figures 19, 20 and 21 show the contrast-detail curves for the 1 1cm phantom under
standard conditions at the optimised CR dose, half that dose and double that dose,
respectively, together with the probability of the chi-square statistic for target
detection frequencies between the CR and DR systems.
\.
0.3 04 0.5 0.ô 0.E 1.0 1.3 1.6 20 25 3.2,4.0 5_0 6.3 8.0
D€püì (rrrt
Group lQFlnv scores
A¡cE. 1oüa, e giqi dÍof lre . 0l
Figure 20. CR and DR image quality at
the optimised CR dose level. Effective
doses are shown.
Chi-square p < 0.66
Figure 21. CR and DR image quality at
half the optimised CR dose level.
Effective doses are shown.
Chi-square p < 0.000027
ryhGÛÙ
Group lQFlnv scores
AlÊ8. 1s014 a Fiûi df dl|m = q
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Contrast Detail Curve
. 1o.01,t, a qlql df of llEË r
I
ò\
'\ 
a\/.
;'ìi
\_.x!.
\ q-.J
0-3 0.,40.5 0.6oE 1.0 f .31-6202s 3¿,1.0 5.043 8-0
Dd'(mi
Group lQFlnv scores
,\¡Ê8. teû4, a Fiqi df cf llEt = q
Figure 22. CR and DR image quality at
double the optimised CR dose level.
Effective doses are shown.
Ghi-square p < 0.67
Page 50
16cm Phantom
Figures 22,23 and 24 show the contrast-detail curves for the 16cm phantom under
standard conditions at the optimised CR dose, half that dose and double that dose,
respectively, together with the probability of the chi-square statistic for target
detection frequencies between the CR and DR systems.
0.3 0.¡l 05 0.6 0.8 1.0 1.3 1.6 2.0 25 32 4.0 5.0 ô3 E.0
Ddh(Írù
Group lQFlnv scores
AltE.lcû{ aF ql df olllEt.0l
0.3 0.4 0.50.60.6 f .01.31.62025 3.2,1.0 5.04340
Ddh(rrù
Group lQFlnv scores
A$E . loof 4, a plol óf d|lEB . q
':_ì.
-L.é
Figure 23. CR and DR image quality at
the optimised CR dose level. Effective
doses are shown.
Chi-square p < 0.011
Figure 24. CR and DR image quality at
half the optimised CR dose level.
Effective doses are shown.
Chi-square p < 0.000012
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AlplE = 1e014, a Êidi dfi of|lÞæ = 0l
0.3 0.4 0.5 0.6 0.8 1.0 1.3 1.6 2.0 2.5 3.2 40 5.O 6.3 &0
oeÉh(m)
Group lQFlnv scores
AIptE = 1è014 a pidi df of |ffi = 0l
.\
\\ \\ \Þ=*.
_-_::l:
Figure 25. CR and DR image quality at
double the optimised CR dose level.
Effective doses are shown.
Ghi-square p < 0.0062
Figure 26. Summary of the chi-square results for the CR/DR comparison under
standard conditions at the three dose levels, each for the three phantom thicknesses.
¿.
N
u
m
b3
oÍ
o2
I
fr
o
s
t
sg
Half Dose Optlmlscd Dosc Doublc Doso
Page 52
4.2 DISCUSSION
Under standard conditions and with the same entrance exposures, the DR system
outperformed the CR system in six of the nine cases. ln these six instances, the DR
curves in figures 16 
- 
24 are closer to the bottom left of the graphs and the chi-
square statistic for target detection frequencies between the two systems was
significant.
For the case of the 6cm phantom at double optimised dose, 11cm phantom at
optimised dose and 11cm phantom at double optimised dose the performance of the
CR an DR systems was similar. ln these instances the contrast detail curve positions
were similar (see figures 18, 19 and 21), and the chi-square statistic for target
detection frequencies was not significant.
Generally, the greatest difference in image quality occurred at the lowest dose levels
(figures 17,20 and 23) and the difference narrowed at the higher doses. This
corresponds to the claimed superior DQE of DR over CR but similar peak
performance found by authors such as Rong et al (Rong et a|.2001) and Neitzel
(Neitzel 2005). The l6cm phantom did not fit this trend though, where the DR image
quality was superior across the range of doses, still markedly so at the highest dose
level (Figure 25). lt should be pointed out though that for the highest dose
comparison the DR effective dose was inadvertently 20o/o higher than the CR. lf this
were not the case the performances would probably have been more similar. This
inadvertent difference in effective dose was despite the same entrance exposures
and was due to the considerably higher tube voltage used for the DR system. 70 kV
was used for the GR system and 81 kV for the DR system, as recommended. The
different tube voltages were necessary to suit the different K-edges of the two image
receptor materials, as discussed in section 3.4. Holding effective dose constant for
the two systems would have avoided this problem but would have been logistically
difficult. The ESEs to be used for the DR system would have to have been chosen
retrospectively, after effective doses were calculated for numerous potential ESEs.
ln most cases the CR and DR tube voltages were more similar and so using equal
entrance surface exposures produced comparable effective doses.
With the exception of Figure 20, the CR and DR curve shapes relative to each other
suggest that the greatest difference in the two systems was in their low-contrast
resolutions. This is supported by the fact that the curves are generally furthest apart
toward the top-left (low-contrast area) of the graphs and closest toward the bottom-
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right (detail area). Some of the CR curves did have a jagged appearance, for
example in Figure 22, which does make a visual comparison of the two systems
harder and less precise. The jagged curves were most likely due to noise effects in
image scoring and whilst not ideal, it is the general curve positions relative to the
graph axes that are more important than the curves' exact shapes. The curve peaks
and valleys can have a pronounced effect on the IQF¡nu values however,
demonstrating the IQF¡nu value's simplicity as an image quality metric.
While it is a simplistic measure, looking at the IQF¡nu values for the two systems in
figures 16 through 24 is still useful. These figures show generally higher IQF¡^,
values for the DR system, suggesting superior image quality. DR IQF¡nu values were
between 4o/o lower than CR for the 6cm phantom at double the optimised CR dose
(figure 18) to 54% higher for the 16cm phantom at half the optimised CR dose (figure
23). The DR IQF¡nu values were 24o/o higher than the CR values on average.
At the highest dose level the DR IQF¡nu values were higher by an average of only
12%. Again this indicates the main difference between the two systems is in their
DQEs, not peak performances. This average value of 12o/o would have been lower
except that it includes the value for the 16cm phantom (DR 28% higher than CR) and
as already discussed, this difference in image quality was due at least in part to the
20o/o difference in effective dose.
The resultforthe 11cm phantom atthe optimised CR dose level (Figure 20) shows
the CR image quality slightly better than the DR. This result does not correspond
with the rest of the findings and could not be explained. Unfortunately by the time
this discrepancy became apparent the CR X-ray room had been decommissioned,
preventing repeating these measurements.
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5. lmage Quality Gomparison of GR and DR under Glinical
Conditions
5.I RESULTS
As with chapter 4, this section contains the CR and DR contrast-detail curves for the
three phantom sizes, each again imaged at three dose levels, but this time under
clinical conditions. Unlike in chapter 4, for this experiment the CR and DR doses
were optimised independently for the reasons discussed in Section 3.4.2.
5.1.1 6cm Phantom
Figures 26,27 and 28 show the curves for the 6cm phantom under clinical conditions
at the optimised dose, half that dose and double that dose respectively, together with
the probability of the chi-square statistic for target detection frequencies between the
CR and DR systems.
Deta¡l
0.3 0.4 0.5 0.6 0.8 1.0 1.3 1.6 2.0 2.5 3.2 4.0 5.0 ô3 8.0
Group lQFlnv scores
AlptE = 1e014 a pridi clffof reæ = 0l
Figure 27. CR and DR image quality,
both at optimised dose levels. Effective
doses are shown.
Chi-square p < 0.0081
Figure 28. CR and DR image quality,
both at half optimised dose levels.
Effective doses are shown.
Chi-square p < 0.0054
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Figure 29. CR and DR image quality,
both at double optimised dose levels.
Effective doses are shown.
Chi-square p < 0.457
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5.1.2 11cm Phantom
Figures 29, 30 and 31 show the contrast-detail curves for the 11cm phantom under
clinical conditions at optimised doses, half those doses and double those doses
respectively, together with the probability of the chi-square statistic for target
detection frequencies between the CR and DR systems.
Figure 30. CR and DR image quality, Figure 31. CR and DR image quality,
both at optimised dose levels. Effective both at half optimised dose levels.
doses are shown. Effective doses are shown.
Ghi-square p < 0.057 Chi-square p < 0.054
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Figure 32. CR and DR image qual¡ty,
both at double optimised dose levels.
Effective doses are shown.
Ghi-square p < 0.84
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5.1 .3 16cm Phantom
Figures 32,33 and 34 showthe contrast-detail curvesforthe 16cm phantom under
clinical conditions at optimised doses, half those doses and double those doses
respectively, together with the probability of the chi-square statistic for target
detection frequencies between the CR and DR systems.
r\
\-_rt 
.-to,,.
0.3 0.4 0.5 0.6 0.8 1.0 t.3 1.6 2.0 2.5 3.2 4.0 5.0 6.3 8.0
ryh(m)
Group lQFlnv scores
AlplE = 1e414 a Ëiqi df of re = 0ì
Alpth= 1ê014 apri clfoflìæ=0l
I
0.3 0.4 0.5 0.6 0.8 r.0 1.3 1.6 2.0 2.5 3.2 4.0 5.0 6.3 8.0
ryh(m)
Group lQFlnv scores
Figure 33. CR and DR image quality,
both at optimised dose levels. Effective
doses are shown.
Ghi-square p < 0.043
Figure 34. CR and DR image quality,
both at half optimised dose levels.
Effective doses are shown.
Chi-square p < 0.0019
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Figure 35. CR and DR image quality,
both at double optimised dose levels.
Effective doses are shown.
Chi-square p < 0.00069
Figure 36. Summary of the chi-square results for the three phantom thicknesses
under clinical conditions. The three dose levels are represented in each thickness.
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5.2 DTSCUSSTON
The results under clinical conditions were very different from those under standard
conditions and varied more between phantom sizes. The DR system performed
either similarly or less well than the CR for the 6cm and 11cm phantoms across the
dose ranges. This can be seen in the proximity of the CR and DR contrast-detail
curves in figures 26 through 31. Chi-square analysis showed the two systems to be
significantly different in only two cases 
- 
for the 6cm phantom at half and optimised
doses. This was due to the CR system's better low-contrast performance. There
was no significant difference at double the optimised dose, as shown in figure 35.
Forthe 11cm phantom there was no significantdifference between the two systems
at any dose level.
The similar performance of the CR and DR systems for the thinnest two phantoms
can be explained by the fact that no additional filtration was used clinically for the 6
and 11cm phantoms for the CR system but was for the DR system (2mm Al). With
the softer CR X-ray beam resulting from not using additional beam filtration, the
image quality was better, particularly the low-contrast performance. As a trade-off for
this improved CR image quality, large differences can be seen in the effective doses
between the CR and DR systems, as shown in the legends of figures 26 through 31.
The CR effective doses were higher by between 3Ùo/o for the 6cm phantom at half the
optimised dose (figure 27) lo 100% for the 11cm phantom at the optimised dose
(figure 29).
The situation was very different for the 16cm phantom (figures 32 
- 
34), where the
results reflect those from chapter 4, with the performance of the DR system
noticeably superior to the CR system. The DR curves here are clearly closer to the
bottom left of the graph, indicating superiority. This is also supported by the chi-
square analysis showing the DR system significantly better at all three dose levels,
as shown in figure 35. Additional filtration was routinely used for large patients on
both CR and DR systems at PMH and therefore it was employed for the 16cm 'large
patient' phantom experiments. Hafnium filtration was used with the CR system and
copper and aluminium with the DR system. Whilst the materials differ, the filtration
had similar effects, evidenced by the results for the 16cm phantom reflecting the
results from the experiment under standard conditions, ie the DR image quality
superior than the CR for similar effective doses. Like under standard conditions, the
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curve shapes for the 16cm phantom suggest the greatest difference in image quality
is in low-contrast performance.
Looking at IQF¡nu values, for the 6cm phantom the CR image quality was 14o/o better
on average than the DR across the three dose levels, but the average effective dose
68% higher. For the 11cm phantom, the CR image quality was 6% better on
average, but the effective dose 91% higher. This marginally better image quality can
not be seen as worth the dÒse 'cost' and so does not indicate that the CR system is
better than the DR system.
Forthe 16cm phantom, the DR IQF¡nu values were on average 24o/ohigher than the
CR values. Due to the more similar beam qualities, the large differences in effective
dose between CR and DR seen for the smaller phantoms are not seen for the 16cm
phantom. The effective doses are comparable in each case, with a maximum
difference of 17o/o (at half the optimised dose level, DR higher).
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6. Dose Gomparison of GR and DR under Standard
Conditions
6.1 RESULTS
This section contains the results for the dose comparison when the CR and DR
image qualities were matched. The experiment was conducted under standard
conditions. The IQF¡n, (blue bars in the graphs) was the parameter held constant
between systems forthe reasons discussed in Section 3.4.3.
Figures 36, 37 and 38 show the differences in effective doses (in the graphs'
legends) for the 6cm, 11cm and 16cm phantoms respectively.
6cm Phantom 11cm Phantom
0.3 04 0.5 06 0.8 1.0 1.3 r.6 2.0 2.5 3.2 a.0 5.0 8.3 8.0
DePô (rrnt
Group lQFlnv scores
AlÊE r 1e¡t¡|, a dqi df oallEË.0l
Figure 37. CR and DR effective doses
for the 6cm phantom at comparable
image qualities (lQFinJ.
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0.3 0.¡10.5 0.6 0.E 1.01.31.6 2.02-5 32,4.010 A3 A0
Ddr(nD
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Altn. 1e{11,1, r pici dfdllE6 ! q
Figure 38. CR and DR effective doses
for the 11cm phantom at comparable
image qualities (lQFi*).
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16cm Phantom
Contrast Detail Curve
Alpha = 1+014 a fridi cll of f|ffi = 0l
Figure 39. CR and DR effective doses
for the 16cm phantom at comparable
image qualities (lQF¡nu).
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Figure 40. Effective doses for CR and DR at equal image quality (lQF¡nu value) for
the three phantom thicknesses.
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6.2 DTSCUSSTON
As discussed earlier, the dose comparison was performed under standard conditions.
This meant the only differences in the radiographic technique were the differences in
tube voltage and slight difference in SlD. Whilst it has its limitations 
- 
which have
been discussed 
- 
holding the image quality figure (lQF¡*) constant for CR and DR
was the only feasible way of quantitatively defining 'equal' image quality and thereby
allowing determination of the dose performance of the two systems. The curve
positions on the three graphs were fairly close in each case, as seen in figures 36, 37
and 38, which does strengthen the argument that the image qualities were
comparable in each case.
For the 6cm phantom, the DR system required an effective dose 0.9 ¡.rSv less than
the CR system to achieve the same image quality. This corresponds to a 36%
patient dose saving for the DR system over the CR.
Forthe 11cm phantom, the DR system required an effective dose 3.7 ¡rSv less than
the CR system to achieve the same image quality. This corresponds Io a 28o/o
patient dose saving for the DR system. For both the 6cm and 1 1cm phantoms, it was
possible to achieve near identical IQF¡nu values with the exposure (mAs) selections
available on the X-ray unit controls.
For the l6cm phantom, the discrete X-ray exposure (mAs) selections available
meant that the closest DR/CR image quality achievable resulted in the DR system
having an IQF¡nu value about 10% higher than that of the CR system, as seen in
figure 38. The DR system required an effective dose 30 ¡,rSv less than the CR
system to achieve the same image quality. This corresponds to a 42o/o patient dose
saving for the DR system. Taking the 10% difference in image quality (lQF¡nu) into
account, the actual dose saving is likely to be higher than the quoted 42%. The
doses that were needed for comparable image quality are shown in figure 39.
As discussed in earlier chapters, the main consequence of radiation exposure in
diagnostic radiography is the increased risk of stochastic radiation effects. An
appropriate risk factor for fatal cancer induction in a paediatric patient population is in
the order of 10% per Sievert (ARPANSA 2005). Using this risk factor, the results
from this experiment suggest that the DR system may offer risk reductions for fatal
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cancer induction of between 9.0 x 10{% per exposure for the 6cm phantom and 3.0 x
1O-ao/o per exposure forthe 16cm phantom. This is assuming that PMH radiologists
were happy with the CR image quality and were prepared to lower the DR exposures
to maintain a similar level of image quality.
With the risk being so low for most individual radiographic examinations, it is perhaps
more useful to consider this potential risk reduction for a population. Based on the
above numbers, the reduction in realised aggregate patient deaths could be up to 3
persons per million X-ray exposures. PMH take in the order of 25000 X-ray
exposures in total per year and so, theoretically, one PMH patient could be saved up
to every 13 years as a result of this change in X-ray equipment. PMH has a relatively
small X-ray department and so the impact of such an equipment change would be
greater in larger institutions.
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7. Conclusions and Recommendations
The performance of the DR system generally outperformed the CR system for image
quality. This included when the two systems were compared under standard
conditions and for the thickest phantom when the two systems were compared under
the clinical conditions at PMH. The exceptions were the two thinnest phantom sizes
under clinical conditions, where the CR system's performance was similar or better
than the DR system. This deviation from the other findings can be explained by the
fact that additional X-ray beam filtration was not employed clinically for patients of
these sizes when imaged with the CR system but was with the DR system. The lack
of additional filtration for CR imaging resulted in softer (less penetrating) X-ray beams
that produced better subject contrast and hence improved image quality; similar to
the DR system. This was, however, at the expense of considerably higher effective
doses.
The DR system offered substantial radiation dose savings over the CR system when
the image qualities were held constant. The potential therefore exists for DR to
provide lower patient doses and image quality comparable to that offered by the
outgoing CR equipment. Alternatively, superior image quality at similar radiation
doses may be deemed more valuable by PMH's radiologists. Whilst this work did not
show dose savings as high as other authors have found in adult radiography, it did
show that the potential dose savings offered by the DR system in paediatrics were
still considerable.
A ROC image quality comparison of clinical images would be a useful next step to
confirm the superiority of the DR system over single-readout CR in paediatric
radiography. Assuming the ROC analysis confirmed the results found in this study,
the enhanced image quality and/or dose reduction offered by this DR system would
mean that the system should be considered by other paediatric hospitals to replace
CR general rooms.
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9. Glossary
AAPM American Association of Physicists in Medicine
AC Alternating current
AEC Automatic exposure control
ALARA As low as reasonably achievable
AP Anteroposterior
CCD Charge-coupled-device
CR Computed radiography
DC Direct current
DQE Detective quantum efficiency
DR Dígital radiography
ESE Entrance surface exposure
FOV Field-of-view
ICRP lnternational Commission on Radiological Protection
ICRU lnternational Commission on Radiation Units and Measurements
IQF lmage quality figure (CDRAD Analyser software)
mAs Product of X-ray tube current and exposure time
MCS Method of constant stimulus
MTF Modulation transfer function
NPS Noise power spectrum
OD Opticaldensity
PA Posteroanterior
PACS Picture archive and communication system
PEP Patient equivalent phantom
PMMA Polymethyl methacrylate
PSP Photostimulable phosphor
QDE Quantum detection efficiency
ROC curve Receiver operating characteristic curve
SID Source-image-distance
SNR Signal-noise-ratio
TFT Thin film transistor
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10. Appendix 1 - Effective Dose Estimations
Following are the effective dose calculations for each for each exposure, calculated
in the software package, PCXMC 1.5.
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PCXMC 1.5 
- Definrtions:
Datafile: p:\¡4asters\Dose cafcs\oR 6cm sL.andard.DEF
Header:
Proj ection:
Ob]. Angle:
Age:
Length:
Mass:
Arms in phantom:
FSD:
X-ray beam width:
X-ray beam height
Xref:yref:
Ztef I
NELevefs:
Nphots:
DR 6cm Standard
270.0000
0.0000
1
14.96A0
9.3600
1
97.0000
16. 0000
16.0000
-0.1519
-5. 6990
8.5071
15
20000
PCXMC 1.5 - Dose va-]-ues:
Datafj-Ie: P:\Masters\Dose cal_cs\DR 6cm standard.ene
Header;
Froj ection:
0b1. Angle:
Age:
tength:
Mass:
Arms Ín phantom:
rSD;.
X-ray beam widtb:
X-lal¡ bean height
xlocus:yf.ocus:
Zfôcus:
NEte\¡el-s:
Nphots:
XYscale:
U scale:X-ray tube voltage (kV);
Fil-ter:
SurfDose:
Org'an:
Ovaries
Testes
Activè bone marrow
skêletan
tungÊ
Lower 1ãrgè intestine
Stomach
tiver
Thyroid
O.esophacus
Brêasts
Urinêry b.1adder
Skln
Ad.renals
Brairr
Kidâeys
Pancreas
.Small intestine
Upper l-arqe inlestine
Spl_een
Thl¡nus
Uterus
Renalnder (muscle)
Gall- þ]adder
Heart
Total Bodl¿
Effective dose
Abs. fraction (?)
DR 6cÍt Stêndârd
270. 0000
0.0000
1-
1 4 .9600
9.3600
9?.00ûå
16.0000
16. 0000
-0. 151 9
_103.4990
8. s071
L5
20000
1.0000
1. 0000
63
3. 5 nun Al + 0.2 rnm Cu
0.0096
Dose (mcy) :
0.005965
0.001740
0. 000833
0.00311-4
0.000380
0.006141
0.007220
0.005367
0.0û000û
0.000252
û.000069
0.009677
0.001 6?2
0.001268
0.000001
û.002238
0. 004r,?o
0.007144
0. 008L70
0. 002916
0. 000111
0. û08002
0. 002599
0. 007 693
0.000534
0. 00250s
0.003593
55 . 697 521
R.rror (g) :
17. 1
¿¿.3
1.0
u.o
4.0
3.1
3.4
12
NA
2L.9
98.1
?a
1.9
'1"7 
,L
46.8
al
7.1
1t
3"0
¿.^
24 .7
L2.9
0.3
6.2
6.4
u.¿
J.Z
PCXMC 1.5 - Dose values:
Datafile: P:\Masters\Þose calcs\DR 6cm s.tândard double.ene
Header:proj ectiÕn:
Obl . AngJ-e:
Age:
tength:
Mass:
A,rms in phantom:
FSD:
X-ray beam width:
X-ray beam heig-ht
Xfocus !yfocus:
Zfocus:
NELevels:
Nphots r
Xyscale:
zscale:
X-ray tube voltage (kV):
FilLei:
SurfDose:
Organ:
Ovaries
Testes
Active bone marrow
Skel_eton
Lun.gs
Lower largie intestine
Sto¡nach
tiver
Thyroid
Oesophagus
Breasts
u¡inaly bfadder
Skin
Açirenals
Erain
Kidneys
pancreas
Small intestine
Upper larg,e intesllne
Spleen
Thymu.s
Uterus
Remainder (muscle)
Galt_ bladder
Ileart
TÕta] Body
Effecti-ve dose
Abs. fracti.on (å)
3.5 n¡¡o
Dose {IrlG}¡) :
o. 0il.381
0.003323
0.001591
0 . 005 945
0.000726
Q.41L724
0. 013784
0.010245
0.000000
0.000482
0.000132
0.0r.8474
0.0031-91
0.oo242t
0.000002
4.0042'72
0. 007 962
0.0r_3638
0.015597
0.005568
0.000212
0 . 01527 6
0. û04961
0.ûl-4686
0 
" 
00101-9
0.004783
0.006860
55 .697s2t
DR 6cm Standard
270.0000
0.0000
1
74.9600
9.3600
I
97.0000
I 6. Q000
16.0000
-0.l-519
-r03.4990
8.5071
15
20000
1. 0000
1.000û
63
Al- + 0.2 run Cu
0.0184
Error(%):
1'7.L
¿¿.3
1-.0
o.B
4.0
3.1
3.4
1a
NA
21 0
98.r
J.¿
1.9
L] .t
46.8
3.1
11
3.0
4.4)a 1
12.9
0.3
ô,1
6-4
o.2
J.¿
PCXMC l-.5 
- Dóse vaLues:
Datafi.Ie: P:\Masters\Dose eal-cs\DR 6cm standard hatf ,ene
Header:proj ecLion:
Obl-. Angi-e:
Age:
tenqth:
Mass:
Arms in phântom:
FgD:
X-ray bêãm width¡
X-ray bean height
Xfocus i
Yfocua:
zfocus:
NELevels:
NPhots:'
XYscaLe:
ZscaLe:
X-ray tube voltãge (kV):
Filt.er:
Sìtrf Dose:
Organ:
ôvaries
Tést9s
ActÍve bone marror,r
skel_eton
Lungs
Lor,rer large inLestine
Stomach
ti-ver
Thyroid
O.esophagus.
Breasts
Urinary bladder
$kin
Adrenals
Brain
Ki.dneys
Pancreas
small intestine
Upper l-arqie intestiûe
Spl-èen
Thymus
Uterus
Remainder (muscle)
Gall- bLadd€r
Heart
Total Body
Effectivê dose
Abs. fraf:tion (*)
DR 6cm Standåfd
2? 0. 0000
0. 0000
I
74.9600
9. 3 600
I
9?.0000
16,. 0000
L6.0000
-0.1s19
-103.4990
8.50?1
l5
20000
1.0000
1.0000
63
3.5 nn Al + 0 .2 mrn Cu
0.0035
Dose (mGy) :
0 . oÔ2169
0.000633
0.000303
0. 00r,132
0.000138
ù -002233
0.00262s
0 . 00 r9s2
0.000000
0 .000Õ92
0.000025
0.0035L9
0.000608
0 . 0004 6t
0.000000
0.000814
0.0û1517
0. 002598
0.00297r
0.001060
0.000040
0 .002910
0.000945
4.aa2791
0.000194
0.000911
0.001307
55 .69"7527
Errôr (ã) :
t7.L
)) ci
1.0
0.8
4.0
.J- L
3.4
L.Z
NÃ
21".9
9€.1
at
1..9
L"7.L
46.8
3.1
7.J-
r.2
3.0
4.4
24.L
1,2.9
0.3
6.2
CAñ')
J.Z
PCXMC 1.5 
- Definitions:
Datafile: P: \Masters\Dose calcs\DR 11cm standard, DEF
Header:
Proj ectton:
Obl. Angle:
Aqe:
Length:
lviass:
Arms in phantom:
FSD:
X-ray beam width:
X-ray beam height
Xref:yref:
Zref I
NELevels:
¡lphots:
DR llcm standard
270.0000
0.0000
5
109.0200
19.1000
1
92.0000
21.0000
21.0000
0 . 1913
- 6. 6990
L0.3294
15
20000
PQXMC 1.5 - Dose val-ues:
Datafite: Pr \Mêsters\DÕse cafcs\DR l1cm standard.ene
Header:
Proj ection:
ObI . Arigle:
Aqie:
Irength:
l,lass:
Arms in phantÕm:
FSD:
X-ray bearr widthr
X-ray beam height
Xfocus:
Yfocus:
.zf.ocus:
NET,evels:
NPhots:
XYEcafe:
Zsca].e:
X-ray tube voltage (kV):
E i-lter:
SurfDose:
Orgån:
Õvarj.es
Testes
Active bone nafrow
Skelet.on
ï,unEs
Lower ]-arge intestine
Stomach
Livèr
Thyroid
Oesophaqus
Breasts
Urinary bladder
Skin
Adrenals
Brain
Kidneys
pancreas
Srnall intestine[Jpper large intestine
Spleen
Thynus
Uterl.s
Remainder (muscle)
Gall- bladder
I{eart
TÕtal Body
Effective eiose
Abs. fractio¡ (?)
DR l-1cm standard
2?0.0000
0.0000
5
r09.0200
L 9. L000
1
92 .0000
21.0000
21.0Õ00
0. 1913
-99.4990
1 0.3294
15
20000
1.0000
1 .0000
?0
3.5 nm AL + 0.2 mm Cu.
0.0333
Dose {mcy) : Error (4.) :
0. 017230 16.20.011089 2r.9
0. t03495 1.10.008629 0.90.000862 5.60.t22623 2.90,022569 2.1
0 . 015545 i,.50.00t000 NA0.000556 26.A0.00000Õ NA
0 . o3 6041_ 5 .20.0û5?04 1.30.00,32'7't 23.A0.000002 78.70.006996 3.90.009494 5.10.025111 0.90.030s87 2.O0.0083?2 5.00.0001?? 26.50..021989 ? . 60.0081865 0.30.02501-? 4. I0.000979 8.50.008490 Õ .20,012493 3.1
56.90941 2
PCXMC 1.5 - Dose values:
Datafilel P:\.Masters\Dose calcs\DR 11cù standard double.ene
Header:proj ecLÍon:
Obl. Angle:
Aqe:
Ler.rgth:
MasS:
Arms in phant.om:
FSD:
X-ray beam r^¡idth:
X-ray beam height
xfocus:yfocus:
Zfocusr:
NELeveIs:
Nphots:
Xyseale:
Zsçale:X-ray tube voltage (kV):
Filter:
SurfDose:
Organ:
ovaries
Testes
Active bone manow
Skeletan
Lungs
Lower large intestine
Stomach
Liver
Thyroid
Oesophagus
Breasts
Urinary bladder
S ki¡r
Adrenals
Brain
Kidneys
pancleas
Smal1 intestine
Upper J-arge intestine
Spleen
Thl¡mus
Uterus
Remaj_nder (muscle)
Gall- bladder
Hearl
Total Body
Effective dose
Abs, fraction (%)
DR l1cm standard
2?0. 0000
0.000ó
5
109. 0200
19. i-000
1
92.0000
21.0000
21. 0000
0. r913
-99.4990
L0.3294
15
2000 0
1.0000
1.0000
?0
3. 5 mnr AI + 0.2 run eu
0.0666
Dose{mGy);
0.034 4 61
o.0z2t17
0.006989
0.017251
0.001?24
a.045246
0.0451.35
0 .03108 9
0.000000
0 .00L111
0.00000.0
a.072A82
0. û11408
Q.006s54
0.000004
0.013992
0.0189S9
0.0s0343
ô.06Lr'7 4
t.016743
0.0003s4
0. 043977
0.017731
0 .050033
0.0019s8
0.0r.6981
0. c24985
56.909412
Error (%) !
16.2
2L.9
1.1
0.9
5.6?q
1.5
NA
¿õ,u
NA
a.¿
1.3
23.0
78.'1
?o
5.?
0.9
2.0
s.0
¿o.3
7,6
0.s
4.9
8.5
0.2
-1 - t
PCXMC 1.5. - Dose val-ues:
Dataf.il-e: P3\Masters\Dasê calcs\DR llcm s.tandard half.ene
Header:proj ection :
Ob]., Angle:
Age:
Leng th:
Mass:
Arms in phantom:
FSD:
X-ray beam width:
X-ray beam height
Xfocus:
Y rocus :
Zfocus:
NEt evel-s:
NphÐts:
Xyscêle l
Zscale:
X-ray tube voltaqe (l<V) :
Fil_ter:
SurfDose ¡
Organ:
Ovaries
Testes
Active bone narrorû
Skeleton
Irunqs
Lower l-arEe intestine
Stomach
Liver
Thyroid
Oesophagus
Breasts
Urinary bladder
Skin
Adr.enaI6
Brêi-n
Kidneys
Pancreâs
SÌna.l-.I intesti-ne
Upper l-arge intestine
.SpIeen
Thymus
Utetlus
RerÞinder (muscLe)
Ga.ll bl-ad.der
Heart
Total tsody
Effectl_ve dos.e
Abs. fraction (%)
DR Llcm standard
270.0000
0.0000
5
t0 9. 0200
l-9. L000
1
92.0000
2l-. 0000
21.0000
0. 19r3
-99. 4990
10.3294
15
2000 0
1.0000
1 . 0000
7A
3,5 mm À1 + O .2 ¡nm Cu
0.0201
Dose (mcy) :
0.010429
0.006711.
0.002115
0.005223
0.000522
0.013693
0.013659
0.009409
0,000000
0.000336
0. 000000
0 . 021814
0. 0û3452
0.001984
0. 000001-
0. 004234
0.005?47
0. 015235
0.019513
0.005067
0. 000107
0.013309
0.005366
0, 015142
0.000592
0.005139
0. 00?56r-
56 - 909472
Error(?):
L6.2
21,.9
1.1
no
5.6
2.9
2.7
I.J
ÑA
26.0
NA
1.3
23.0
78.7
10
no
2.0
5.0
26.5
1.6
û.3
4.9
8.5
?1
PCXMC 1.5 
- Definit-ro¡rs:
Datafile: P: \Masters\Dose calcs\DR
Header:
Proj ection:
Obl. Angle:
Age:
Length:
MâSS:
Arms in phantom:
ESD:
X-ray beam wiclth:
X-ray beam height
Xref:yref:
Zref:
NELevefs:
NPhotS:
L6cm sta¡rdard.DEF
DR l6cm standard
270.0000
0.0000
15
1 63 . 9900
54 .5000
1
86.0000
31.0000
3r .0000
-0. B0B7
-8.9892
76 .'t I2B
15
20000
PCXMC 1..5 
- Dose va.Lues:
Datafile: p:\Masters\Dose calcs\Dn fOcm standard.ene
Header:
prc!J ection:
Obl. AnEfe!
Age:
Length:
Maas:
Arms in phantom:
FSD:X-ray beam width:
X-Íay bean height
Xfocus:yfocus:
Zfocus:
NEl,evels:
NPhots:
Xyscale:
Zsca].e:
X-x.a]t tr¡be voJ-tage {kV.) :
Ff l_ter:
SurfDose:
orqan:
Ovaries
Testes
Active bon.e marrow
skeleton
tunEsIolier large intestine
Stomach
tiver
Thyrôid
Oesophaqus
Breasls
Urinary bladder
Skin
Adrenals
Brain
Kidneys.
Fãncreas
Sma]L intest.ine
Upper l-arqe inLestine
spleen
Thlrnus
Uterus
Remainder (muscle)
Gall bLadder
Heart
fobal Body
Effective doseAbs. fraction (g)
DR 16cm stan.dard
270.0000
0.0000
15
l_63.9900
54 .5000
1
86.0000
31.0000
31.0000
-0.808?
_95.7892
L6.7r28
t-5
20000
1 .0000
1.0000
8l-
3..5 rnm A1 + 0.2 ¡nm C¡Ì
4.2339
Dose(mcy):
0.139436
0.03.?073
0.023970
0.04 6850
o.004138
0 . l-3 6040
0.1608s3
0.088211
0 .000092
o,Ða2228
0 .002098
o.2;9234
0.040668
0 .01-4097
0.000001
0.042653
0 .05948Õ
0.166103
0.191596
0.046058
0.00û709
0.L67952
0.0s9306
a.189322
0 . 00 6385
0.057029
0 .08138 6
60 
- 
412223
Error(å) :
11.1
13.1
1. l_
0.7
7.û
2,.8
3.0
1.5
100.0
J¿ . O
33. 9
3.2
1ò
tB.û
100.0
?o
qo
1l
)?
A1
53.3
4.2
0.2
4.5
o.l
u.¿
z-z
PCXI{C 1,5 
- Dose val-ues:
Datafile: p:\Masters\Dose calcs\DR 16cm standard double.ene
Header:proj ection:
Obl-. Angle:
Age:
Length:
Mass:
Arms in phantom:
FSD:
X-ray beam r^ridth:
X-ray beam height
Xfocus:yfocus:
Zfocus:
NELeVe.IS:
Nphots:
Xyscale i
Zscale:X-ray tube voltage (kV):
Filter:
SurfDose:
Organ:
Ovaries
Testes.
Active bone magow
Skefêtorl
Lungs
tor¡¡èr l-arge intesti-ne
StoÍlach
Liver
Thyroid
Oesophagus
Breasts
Urinary bÌadder
Skin
Adrenals
Brain
Kidneys
pancreas.
Small- intestine
Upper large intestine
SpIeen
Thymus
uterus
Remainder (muscle)
Gal-1 þl-adder
Heart
Total Bod]¡
Effective dóse
.A,bs . fraction (ts )
DR 16cm standard
270.0000
0.0000
15
r63.9900
54 .5000
1
86.0û00
3L.0000
31.0000
-0. B087
-95.1892
16,-]1.28
15
20000
1 .0000
1 . 0000
8L
3.5 nn Al + 0.2 mû cu
0.4669
Dose (mcy) :
0.278350
0.0?400?
0.047850
0.093525
0. 008261
0.2-7t571
0. 321104
0 . 11 6092
0.000184
0.004448
0.004188
0.497535
0.081"185
a.o2BL42
0. 000003
0, 085145
0. 118738
0.331-583
0.38241 4
0.091943
0.00141 5
0,3352'7 4
0.118391
0. 377936
0 . tL2-t 46
0. 113845
0.L62467
60 .472223
Error(%):
11.1
13 .1
11
0.7
7.0
2,8
3.0
1.5
100.0
32 .6
?? o
3.2
1t
18 .0
1-00. Ò
?o
qq
t.J
4.7
53.3
A)
0.2
¿q
8.?
4.2
2-2
PCXMC 1.5 
- Dose val-ues:
Dâtafil-e: P:\.Mastèì.s\Dose calcs\DR l6crn stãnda.rd half.ene
Header:
Pro j ection :
Ob1. Angl.e:
Aqe:
l,eûgth:
Mass:
Arms in phântom:
FSD:
X-ray beam width:
X-ray beam height
Xfocus:yfocus:
z fÕcus :
NEtevefs:
NPhots:
XYsca].e:
zscale:
X-ray tube voftaqe (kV) :
Fl1ter:
Surf Do,se:
Organ:
ovaries
Testes
AcLive bone ¡narrow
Skel-eton
l,unq.s
Lor,,er Larqe lntestine
Stomach
Live r
Thyroid
Oesophagus
Breasts
Urinary bladder
S kin
Adrena.ls
Brain
Kidneys
Pancreas
Small- intestine
Upper farge intestine
Spleen
Thymus
Uterus
Reñainder (nuscle)
GaIt bladder
Heart
Tobal Body
Effeclive dose
Abs. frâction (B)
DR i-6cm standard
270.0000
0.0000
L5
163. 9900
54.5000
L
86.0000
31.0000
3r.o000
-0. 80 87
-95.'t892
16.7728
15
20000
1.0000
1.0000
8l-
3.5 mm Al_ + 0.2 mm Cu
0.0929
Dose(mcy): Error(%):0.0553s7 1r.t0.014718 13. I0.009516 1.1û.018600 0.70.001643 ?.0
0.054008 2 .B0.063859 3.00.035020 1.50.00003? 1û0.00.000885 32 -60.00083.3 33.90.098947 3 .20.016146 t.20.005597 18.0
0. 000001 100.00.016933 3.90.023614 s-q0.065943 1.30.076064 2.30.018285 4.70.Ô00282 53.30.066671 4.20.023545 0 -2û.0?5162 4 .50.002535 8.74.022647 0.20.032310 2.2
6A.AL2223
PCXMC 1.5 - Definitions:
Datafife: P: \Masters\Dose
Header:
Proj ection:
Obl. Angle:
Age:
Length:
MaSS:
Arms in phantom:
FSD:
X-ray beam width:
X-ray beam height
Yrof .
yref:
Zref i
NELevels:
NPhots:
s tandard . DEF
CR 6cm Standard
270.0000
0.0c00
1
7 4 .9600
9.3600
1
91.0000
16. 0000
16. 0000
-0. 151-9
-5.6990
8.5071
15
20000
cafcs\CR 6cm
PCXMC l-.5 
- Dose va.l"ues:
Datafile: P: \Masters\Dose
Header:
Projection l
Obl . AngJ.e:
Age:
Lenqth:
Mass:
in phantom:
FSD:
beam úidthr
beam heiqiht
Xfocus:
Yfocus:
Z focus :
NELevels:
NPhots:
XYscale:
Zscale:
91.0000
16.0000
1 6. 0000
-0. 1519
-97 .4994
8.50?1-
15
20000
1.00û0
1. 0000
58
0.2 mm Cu
0.0096
Error (%.) :
L6.2
¿o,¿
0.9
a.'1
4.t)
4.4
3.8
1a
I.IA)1 A
100.0
4,2
2.0
¿u.-)
50.0))
1.5
3.6
Õ.2
L2.4
n?
6.4
7.8
J.J
calcs\CR 6cm standard. êûe
CR 6cm Standard
2t0.0000
0.0000
l-
'7 4 .96AA
9.3600
IArms
X-ray
x-ray
X-ray tube voltage (kV):
Fil-ter !
SurfDose:
Qrg'an:
Ovaries
Testes
Active bone marrow
Skeleton
Lunqs
ï,or^¡er l-arge intestine
Stomach
Liver
ThyrÒid
Oesophaqus
Breasts
Urinary bladder
Skin
Adrenals
Brain
Kidneys
pancreâs
SmalL intestine
Upper l_arg,e intestine
Spleen
Thymus
Uterus
Remainder (muscle)
Gall bladder
Heart
Total Body
Erlectt-ve dose
Abs. fraction (ã)
3. 5 rûri AI +
Dos.e (ncy) :
0. 00 6053
0.001163
0.000750
0.00291-3
0.000336
0.00s604
0.00699r
0.005112
0.000000
0. 000201
0. 00002s
0. Ô08841
0.001694
0. 001099
0.000001
0.002009
0. 004028
0.006637
0. 007 838
0.002604
0.0001-00
0 . 007 154
0.002449
0.007402
0 . 0005 r6
0. 0023 61
0. 003383
5B. 675814
PCXMC 1.5 
- Dose va.Il:es:
Datafil-e: F:\Masters\Do.se calcs\CR 6crn standâ.rd double.ene
Header:proj ection:
Ob1. Anqlel
Age:
tength:
Mâss:
Arms in phartomr
ESD:
X-ray beam wl_dth:
X-ral¡ þeam heigl:t
Xfocus:
yfocus !
U focus:
NE].evel_s:
Np.hots:
Xyscale:
Zacale:
X-ray tube vol,tage (kVI:
Filter:
SurfDose:
Orqan:
Ovaries
TestesÄctive bone rnarrow
Skeleton
tunqs
Lovrer _large intestine
Storirach
Liver
Thyroid
0esop,haqus
BreaSts
Urinary blãdder
S kin
Adrenals
Brain
Kidneys
pancreas
smãl_l iûtestine
Upper 1arqe intestlne
Spleen
Thymus
Uterus
Remainder. (muse]e)
GáIl bladder
Heart
Tota-l Body
Eff,ecLive dose
Abs. fraction {å)
CR 6cn Standard
270 
-0000
0,0000
1
74. 9600
9.3600
1
91.0000
16. 0û00
t_6. 0000
-0. 1519
-9?.4990
8.507r-
l5
20000
1.0000
1.0000
583.5 nm AL + 0.2 nm Cu
0.0201
Dose (mGy) I
0.01265?
a.002432
0 . 00 1568
0.006090
0. û00702
0.01r.?1?
0 .01461_8
0.010689
0.000000
0. û00420
0.000048
0.018485
0. 003543
0.00229?
0. 000003
0 . 0042û0
o.0Ð.8422
0.0138?8
0 . 01 6389
0.005445
0.,0 00209
0.0r.4959
0.00sr21
0.0154?7
0.001080
0.004936
0.00?0?3
58. 675814
Error (t) :
\o 
- 
l
¿o. ¿
0.9
0.?
4.6
4.4
3.8
1)
NA
21 .4
100. 0
4.2trì
20.3
50. 0
J.J
?.5
1,5
3.6
ô.2
23.7
1) 
^0.3
6.4
't.8
a.2
3.3
PCXMC 1.5 
- 
Dose values:
Datafile: P:\Masters\Dose cafcs\CR 6cm standard ha1fa. ene
Header:
Proj ectiÕn:
OLil . Angle:
Aqe:
Length:
Mass:
Arms in pkrantom:
FSDr
X-ray beam width:
X-ray beam height
Xfocus:yfocus:
Zfocus:
NEtevel-s:
NPhots:
Xyscale:
Zscal_e i
X-ray tubìe voltaqe ( kV) :
Fitter:
SurfDose:
organ:
Ovâries
Testes
Active bone marrow
Skeletori
Lur.lgs
toÍ¡er largê intesti.qe
Stoma.ch
Liver
Thyroid
Oesophagus
Breåsts
Urj.nary bladder
Skin.Àdrenals
Brain
Kidneys
pancreas
Small intestine
Upper farge intestine
Spleen
Thymus
Uterus
Remainder (muscle)
Gall bladder
Heart
Total Body
Effective dose
Abs. fraction (?)
3. 5 m¡û
Dose (mcy) :
Õ.4a2752
0 .000529
0.000341
0.001324
0.000153
0.4a254,'1
0.003178
a.tû2324
0 .000000
0.000091
0.000010
0.004019
0. 000770
0.000499
0.000001
0.00091_3
0.001831
0.003017
0.003s63
0.001194
0.000045
a.403252
0.001113
0.003.365
0.000235
0.001,073
0.001538
58 . 6?5Sr.4
CR 6cn Staridard
2?0.0000
0.0000
1
74.9600
9.36Û0
1
91 .00û0
16.0000
16.0000
-û.1519
-.91 
.4990
8.5071
15
20000
1.0000
l-.0000
ÉÒ
A1 + 0.2 nun Cu
0.0Cr44
Ðrror(å):
16.2
¿o. ¿
0.9
0.7
4.6
aa
3.8
1?
NA
2't .4
10t.0
4.2
2.ú
2Q.3
50.0
3.3
7.5
1.5
3.6
o.¿
23.7
L2 .4
0.3
6.4
1.8
û.2
3.3
PCXMC 1.5 - Definilions:
Datafíl-e: P: \Masters\Dose
Header:
Proj ection:
Obl. Angle:
Age:
Length:
Mass :
Arms in phantom:
rqn'
X-ray beam width:
X-ray beam height
Xref:yref:
ZTef.:
NELeVefS :
NPhots:
calcs\CR 11cm stândard. DEF
CR 11c¡n standard
270. 0000
0.0000
5
r0 9 . 0200
19.1000
I
I 6. 0000
21.0000
21.0000
-0. 5?38
-6. 6906
L0.1I20
15
20000
PCXMC L,5 
- Dose values:
Datafile: p:\Masters\Dose calcs\CR l1cm stândard.êne
Header:proj ection:
ôbl , AngJ-e:
Age:
Lenqtht
Mass:
AÌm5 in phantortl:
FSD:
X-ray beam width:
X-ray beam heiqht
Xfocus:
Yfocus:
zfocus:
NELevel-s:
Nphots:
Xyscale:
U scal,e !X-ray tube vôltaEe {kV):
Fi_tter:gurfDose:
Organ l
Ovaries
TestesÀctive bone marlow
Skeleton
Lungs
Lower larg.e intestj-ne
Stomach
Liver
Thyroid
Oesophaqus
Breasts
Urinary bladder
Skin
Adrenals
Brain
Kidneys
Pancreas
Smal-l intestine
Upper l-arge intestine
Spleen
Th\¡mus
Uterus
Remainder (musc]-e)
Gafl bl-adder
Heårt
Total Body
Effective dose
Abs. fraction (?)
CR ]-1cm sLandard
?70.0000
0.0000
5
r09.0200
19.l-000
L
86.0000
21 .0000
21.0000
-0.5738
-93.4906
10 . 71-20
1"5
2000Q
1.0000
1".0000
62
3, 5 nm Al. + 0,2 mrri Cu
0.0377
Dose(mcy):
0.0195L1
0.01279r
0.003186
0.008220
0.0009û8
0.02L728
0.024118
0.017449
0 .000000
0.000569
0 ,000000
0.036871
0. 006345
0 .0028? 9
o.000002
0,006856
0.00977r-
a.û25152
0.031347
0.009014
0.000114
a .0270"7 6
0.009113
0.a29102
0.001244
0.008683
0.013202
59. ?2 6590
Ërror(Ê):
1-4.3
24.'7
0.9
0.'7
7,4
J,¿
3.1
1, .5
NA
l-0Õ.0
¿. ')
1.6
28.L
E? ¿
4.6
6.0
1,5
a1
5.4
39 .9
L2.L
0.2
4 .'7
8.0
0.2
3,4
PCXMC 1,5 
- Dose vaÌues:
Datafiler P:\Masters\Dose cafcs\CR 11crn standârd clouble.ene
Heade r :
Proj ection:
Obl. Ang].e:
Aqe:
Length:
Mass:
Arrns in phantom:
FSD:
X-ray beam wicith:
X-ray beam height
Xfocus.:
Yfocus:
Zfocus 3
NELêvela:
NPhots:
XYscale:
Zscale:
X-ray tube voltage (.kV) :
E.ilter:
SurfDose:
Organ:
Ovaries
Testes
Active bone maffoi¡
Skeleton
Lunqs
Lower large intestj_ne
SLomach
Liver
Thyroid
Oesophagus
Breasts
Urinary bladder
Skin
Adrena.l_s
Brain
Kidneys
Pancreas
Small intest.i ne
Upper larqe intestine
spfeen
Thymus
IJterus
Remainder (muscle)
Ga]'l bladder
Heart
Total Body
Effective dose
Abs. fraction (?)
CR 1lcm standard
270.0000
0.0000
3.5 Íìn Al +
Dose (mGy) :
0.039022
0.025582
0.006312
0,016439
0.001815
0.043457
0,048236
0.034899
0.000000
0.001138
0 .000001
0.Ð't3"1 43
a .0L2690
0.005759
0.000003
0.013713
0.019543
0.050304
0.a62693
0.018027
0.000221
0.0541-53
0.018225
0 .0582 0 4
0.002488
0. 0173 66
a.0264Q4
59."126590
109.0200
19.1000
1
86.0000
21.0000
21.0000
-0.5738
-93.4906
10.7120
l5
20000
1.0000
1.0000
62
0.2 rim cu
0.0753
Error(3) r
1¿ ?
24.1
0.9
0.7
7.4
?1
?¡
1.5
IJA
23.5
t-00.0
4.2
1.6
28,L
53.4
4.6
6.0
2.7
AA
39.9
12.7
4.2
4.'l
8.0
u.¿
?. ¿.
PCXMC 1.5 
- Dose val-ues:
Datafil-e: P:\Masters\Dose
. Hêader:proj ection:
Obl. Angle:
Aqe:
Irength:
Mass:
Arns in phantom:
FSD:
X-ray beam width:
X-ray bêam height
Xfocus:yfocus:
ztocus:
NEtevels:
NPhots:
XYscal-e:
Zscal,e:
X-ray tube voltag.e (kv):
FÍIter:
SurfDo.se:
O.rgan:
ovarl-es
!estês
Active bone marro-¡¡
Skeleton
Lunqs
Lolier large intestine.
.Stomach
Liver
Thyroid
Oesophagus
Breasts
Urinar)f blad.der
skin
Adrenals
Brain
Kidneyspancreas
Smal-1 intestine
Upper large intestine
Spleen
Thl¡mus
Uterus
Remainder (muscle)
Gall bladder
Heart
Total Body
Effective dose
Abs, fràction (*)
cal-cs\CR l1cm standard half.ene
CR 1l-cm standard
270.0000
0.0000
5
1 09.0200
19.1000
I
86,0000
2r.0000
21.0000
-0.5738
-93 .4906
10.7120
15
20000
1.0000
1. 0000
o¿
3.5 run Al + Q. I n¡¡ g¿
0.0r84
Dose (mcy) :
0.009s29
0.006241
0.001556
0.004014
0.000443
0 -010612
0.01 1779
0.008522
0.000000
0.000278
0.000000
0 .01-8007
-0.003099
0.001406
0.000001_
0.003348
0.Q04712
0.012283
0 .015309
0.0û4402
0.0000ss
0.013223
0.0044s0
.0.014213
0 . 000 608
0 .00424A
a.00644't
59.126s90
Error(?):
f À a
24.7
0.9
0.?
7.4
J.¿
3.1
1.5
NA
?? 6
100.0
L)
1.6
28.L
5? ¿
4.6
b-tJ
1.5
2.7î, ¿.
?o o
1a I
0.2
Ãa
8.0
4.2
3.4
PCXMC 1.5 
- DefiniLions:
Datafile: p: \Masters\Dose caLcs\CF. 16cm siandard.DEF
I{eader:
Proj ectron:
Obf. Anqle:
Age:
Length:
lvlass:
Arms in phantorn:
FSD:
X-ray beam ¡idth:
X-ray beam heiqht
Xref:yref:
Z-ref i
NELeVeIS:
NPhots:
CR 16cm standard
27 0 . 0000
0.0000
15
I 63 . 9900
54 .50C0
1
77 .0000
31.0000
31.0000
-0.8087
_s 
.9892
L6 .1L28
15
20000
PCX¡4C 1.5 
- Dose val-ues:
DatâfiLe : p i \Nta€ters\Dose
Header:proj ection:
Obl . Angl-e:
Age:
Length:
Masst:
A.rms in phantom:
FSD:
X-ray beam width:
X-r.ay beam height
Xfocus:yfocus:
Zfocus ¡
NEl"eve1s i
Nphots:
Xysca.Le:
zscal-e:X-ray tube voltage (kV):.
Ei_Iter:
SurfDose:
Orqan:
Ovaries
Testes
Active bone marro¡¡¡
Ske].eton
tungs
Lower .l-arge intestine
Stomach
Liver
Thyroid
Oesoltlaqus
Bre.ASts
Urinary bladder
Skin
Ii.drenal-s
Bräin
Kidneys
pancreas
Sma]L inte.stjne
Upper large intestine
Spleen
Thymus
Uterus
Renrainder (muscle)
Gall kil_adder
Heart
Tot.ãf Body
Affective dÕse
.¡¡,bs. fraction (å)
ca-lcs \CR 1 6c¡n s t¿rndard . ene
CR L6cm standard
270.,0000
0.0000
15
163.9900
54.5000
1
77 .0000
31.0000
3t-.0000
-0.808?
-86.7892
L6.,7128
15
200 00
1. o000
1 .0000
703.5 ûìm Ä1 + 0. ! ¡un ¡¡
0 .2313
Dose (nGy) :
0.117098
0. û37757
0.019787
0.040717
0.003440
a .]_L2'7 63
0. 138597
0.a'77773
ü.000060
0. 001532
û.001365
ô.222336
0.037894
0.01251B
0 .00û000
0.031868
0.0567?5
0.L43295
0.772316
0.041566
0 .0004? 6
û.148499
a . a5z1 3I
0. 169205
0 .0051 04
0.050476
0.0709.61
63 .16't 673
Erfor(å):
12.0
14 .8
0.9
0.8
6.1
4.0
3.4
L.7
10û .0
32.3
54. Oqâ
25.2
NA
a'1
5.4
1.5)t
7 .4.
54 .6
4.6
0.3
?a
'tn 1
nt
¿.4
PCXMC l-.5 - Dose values:
Datafii.er p:\Masters\Dose calcs\CR 16cn standard d.ouble.ene
Heade.r:
prÕj ectioo:
Obl . AnqJ-e:
Age:
Length:
Mass:
Arns j.n phantom:
FSD:
X-ray bealn wj,.dth:
X-ray be.êa height
XfÕcus Iyfoeus:
Zfocus:
NELevels:
NPhots:
Xysc.ale:
Zscale:X-ray tube voltage (kV):.
Filter:
SurfDosê:
Organ:
ovâries
Testes
Active bone marrow
Skeletqn
Lur'rq:s
Lower larqe intestine
Stomach
Liver
Thyroid
OesophaEus
B.reast.s
Urinary bladder
Skin
Adrenafs
Brain
Kidneys
pancreas
Smål1 intestinê
Upper large intestine
Spleen
Thymus
Uterus
Rema j nder (nuscl-e)
Gaf1 bladder
Hearl
Total BodyEffe.ctive dose
Ab.s. fraetiôn (%)
CR 16cm standârd
270.0000
0 .0000
L5
163.9900
54.5000
t
77.0000
31.0000
31.0000
-0.80{l?
*86.'1892
16.1L2.8
15
20000
1.0000
1 .0000
7Q3,5 mm At + 0,2 nm Cu
0.4406
Dose (mcy) :
o.223LA6
0.071938
0,035796
0.4175t8
0.0065ss
0.21484,1
0.264A1A
0.148182
0.00r0114
0 .002 919
0.00260r
0 .4236].7
0.a72L99
0.0238s1,
0. Ò0öo00
0.06071?
o .1a8174
0 -273A20
0. 3283 l3
0.079196
0.000908
0.282936
0.100469
0.32238?
0.009725
0.0961?1
0.135201
63 .'t 67 67 3
Effor(*):
12.a
14.8
no
0.8
6. l-
4.0
3.4
1.7
100.0
32.3
54,0
5.4
r,2
25.2
NA
4.3qa.
1.5
7.4
s4.6
4.6
0.3
?q
10.7
0.2)q
PCXMC 1.5 - Dose valuesr
DatafiLe: P:\Masters\Dose calc.s\ÇR 16cm standard ha].f ..e-ne
Heâder:
Þroj ection I
ObJ-. ArÌgle I
Age I
T,ength:
l,Iâss:
Arms in phantom:
FSD:
X-ial¡ beam width:
X-ray beam height
Xfocus:yfocus:
Zfocus l
NELevel"g:
ñphots:
Xyscè1e:
Z s.cal_e:
X-ray tube vollage (kV):
Fi I ter:
SurfDose:
Organ:
ovaries
Te€tes
Active bone rnarfow
Skeleton
tu¡gÊ
LOÍ¡er larg:e int:stine
Stonûach
.LLver
Thyroid
Oesophagus
Breastrj
Urinary bl-ådder
Skin
Adrenal-s.
Brain
Kidneys
pancreas
Small intestine
Upper largie intestine
6p1een
Thlûnus
üterus
Remainder (iltuscle)
Gall, bladder
Heart
Total Bo.dy
Effêctive dose
Abs. fraction (å)
CR 16cm standard
2?0.0000
0.000Õ
15
163.9900
54.5000
1
77.0000
31.0000
3r.0û0û
-0.8087
-86 .'t 892
L6.7L28
t-5
20000
1.0000
1.0000
?0
3.5 nm At + 0 .2 m¡n Cu
0.1034
Dose {nrGy) : Error (å ) :û.052339 1,2 -A0.016€76 l-4.80.008397 0.90.018199 0.80.001538 6.7
o.0s0401 4.00.061949 3.44.034'762 l.?0.000027 100 . Q0.000685 32.30.000610 54 .00.099377 5 .40.016937 L.20.00559s 25 -20.000000 NA
o.oL4244 4.3
0. 025377 5 .40.064048 I .5Q.077020 2.20.018s79 7 
-40.000213 54.60.066375 4.60.023569 Õ.30.075630 3.9
0 . 002281 r0. ?0,0.'225.6L A.20.031717 2.5
63 .1 61 6:t3
PCXMC 1.5 
- Definitions:
Datafile: P:\Masters\Dose ca.lcs\DR 6cm
Header:
Proj ection:
Obl . Angile:
Age:
Length:
Mass:
Arms in phantom:
FSD:
X-ray beam width:
X-ray beam height
Xref:yref:
Ztef:
NELevefs:
NPhots:
cfinicaÌ. DEF
DR 6cm Clinica]
270.0000
0.0000
1
1 4 .9600
9.3600
1
97.0000
16.0000
I 6. 0000
-0. r519
-5. 6990
8.507r
15
20000
PCXMC 1.5 
- Dose va.lues:
Datafile: p:\t4asters\Dose calcs\DR 6cm clini,cal.ene
Header:proj ection:
Obl. Angle:
Age:
Length:
Mass:
Arms in phantom:
FSD:
X-ray beam width:
X-ray be.arn height
Xfocus:yfocus:
Zfocus:
NEIreveIs:
Nphots;
Xyscale:
zscale:
X-ra!¡ tube voltage (kV):
Fi_l_ter:
SurfDose:
Organ:
Ovaries
Testes
Active bone marrow
Ske].eton
Lungs
Lor^¡er large intestine
Stomach
tiver
Thlzroid
Oesophagus
Breasts
Urinary bladder
SkÍn
Adrenals
Brain
Kidneys
Pancreas
S¡nal]. intestine
Upper farge j-ntestine
Spl_een
Thymus
Uterus
Remainder (muscle)
Gal-1 bladder
Heart
Total Bodl¡
Effective dose
Abs. fraction (g)
DR 6cm C]inical
270.0000
0.0000
t-
7 4 .96t0
9.3600
1
97.0000
16.0000
l-6.0000
*0. t-519
-103 .4990
8.5071
15
20000
1-.0000
1.0000
o-t
4.5 run A1
0.0185
Etror (g) :
1-7.3
a1 â
0.9
0.7
4.3
?¿
3.0
r,¿
NA
22.3
98.2
3.1
1.7
16. 0
qq ¿
3.2
6.7
L.2
t1
4,9
'E 
Ã
t-3.0
U.J
qÁ
6.2
0.2
3.0
Dose (mcy) :
0.00?728
0.002326
0.00L091"
4.004294
0.000478
0.008579
0 . 0110 60
0.008010
0.000000
0.000278
0.000060
0.01,4847
0,002908
0.0016s1
0.000001
0.002885
0.00s499
0.009983
0.011667
0.003956
0.000126
0. 010932
0 . 003 937
0.011-263
0.000670
0.003'729
0.005172
61.1361_35
PCXMC 1.5 
- 
Dose values:
Datafile: P:\Masters\Dose cal-qs\DR 6cm clinical half.ene
'DR 6cm Clinica]
270.0000
0.0000
Header:
Proj ection:
Ob1 , Angl-e:
Age:
Length:
MasS:
Arms in phantom:
FSD:
X-ray beam width:
X-ray þeam height
XfÕcus:yfocus:
z.focus:
NELevels:
NPhots:
XYsca].e:
zscale:
X-ray tuhe voltaqe (kV):
Fi].Ler i
SurfDÕse:
Orgian:
Ovaries
Testes
Active bone marro¡rr
Ske].eton
tungis
Lower largie irÌtestine
Stomach
f,iver
Thyroíd
Oesophagus
Breasts
Urinâry b].adder
Skin
Ad.renal-s
Brain
Kidne.ys
Pancreas
Small intestine
Upper large intestine
Spleen
Th!¡mus
Uterus
Remainder çmuscle)
GaIj- bladder
Heart
Total Body
Effective dose
Abs. fraction (%.)
Dose(mcy):
0.004395
0.001_323
0 . 0.00 620
0.a02442
0.00Õ272
0.0048?9
0.006290
0.004555
0.000000
0.000158
0. 0û0034
0.008444
0. 0ûL654
0. 000939
0.000001
0.00164r-
0.003r27
0.005677
0.00663s
0.002250
0. 000071
a.oa62r1
a.002239
0,00640s
0.000381
o.002t2L
0.002942
61.136135
1
7 4 .9600
9.3600
L
97.0000
r.6.0000
16.0000
-0 . 15l-9
-103,4990
8.5071
l-5
20000
r-.0000
1 .0000
63
4 .5 ÍEn .41
0.0105
Error(E):
71 .3
22.6
0.9
0.7
4.3
3.4
3.Q
L.2
NA
22.3
98.2
3 .1-
1-7
1"6.0
55.4
l,
0. /
L,2
aa
4.9
aE rZJ . J
l-3.0
^)
5.6
6.2
0.2
J.U
PCXMC L.5 
- Dose values:
Dataflle: P3 \Masters\Dose
Header:
Proj ection:
Obl-. Angl-e:
ãgs t
Length:
Mass:
Arms in phantom:
FSD I
calcs\DR 6cm clinical- doubl-e. ene
DR 6cm Clinical
270.0000
0.0000
1
7 4.9600
9.3600
l-
X-ray
X-ray
97.0000
l-6.0000
16. 0000
-0.1519
-l-03 . 4 990
8.5071
1-5
20000
1.0000
1.0000
63
4.5 mm A1
0. 0333
Error(%):
1_7.3
¿¿ .6
0.9
0 .'7
AA
AA
3.0
r.2
NA
t) a
qA)
?1
1.7
l_6.0
55.4
1a
6.7
1)
)'l
do
2q q
13. 0
U..J
5.6
6.2
u-z
3.0
beam width:
beam height
Xfocus:
Yfocus:
Zfocus:
NELeVeIS:
NPhots:
XYscaIe I
Zscale:
X-ray tube voltage (kV) :
Filter:
SurfDose l
Organ:
Ovaries
Testes
Active bone marrow
Skeleton
Lungs
Lohrer large i_ntestine
Stomach
Liver
Thyroid
Oesophagus
Breasts
Urj_Rary bladder
Skin
Adrenals
Brain
Kidneys
Pancreas
Small- intestíne
Upper large intestine
Spfeen
Thl¡mus
Uterus
Remainder (muscle)
Gafl- b].adder
Heart
Total Body
Effective dose
Abs. fraction (3)
Dose (mcy) :
0 . 01_3 918
0.0041-88
0.001964
0.007733
0.000861
0.015450
0.019918
0.014425
0.000000
0.000s01
0.000109
0.026738
0.005238
0 .00297 4
0.000002
0.005196
0.009904
0 .0L7 91 9
0.02L0t2
0.o071-24
0 .0a0226
0.019688
0.007091
0.020283
0.001206
0.006716
0.009315
6L . l-3 613s
PCXMC 1.5 
- Definitions:
Datafife: P: \Masters\Dose
Header:
Proj ection:
Obl-. Angle:
Ag'e:
Length:
Mass:
Arms in phantom:
FSD:
X-ray beam width:
X-ray beam height
Xref:yref:
Zref i
NEl,evef s:
NPhots:
cafcs\DR l1cm clinical.DEF
DR llcn clinical_
270.0000
0.0000
5
109.0200
r9.1000
1
92.0000
21.0000
2l-.0000
0. t-913
-6.6990
r0.3294
15
20000
PCXMC 1.5 - Dose va.lues:
Datafj-le: P¡ \Masters\Dose
Header:
Pro j ection.:
Obl . Ang-Ie:
Age:
Lenqth:
Mas.s:
Armg in phantom:
FSD:
X-ray beam width:
X-ral¿ beam height
Xfocus:
Yfocus:
zfocus:
NELeveLs:
NPhots:
.XYscaLe r
zsêa1e:
X-ray tube vol-tage (kV):
Eilter:
SurfDose:
Orqan:
Ovaries
Testes
Active bône maf,row
Skeleton
Lungs
Lo&rer 1arqê intestine
Stomach
Liver
Thyroid
Oesophagus
Breasts
Urinary bladder
Skin
Adrenals
Brai-rr
Kidneys
PancIeas
Smal1 intestine
Upper large intestine
Spleen
Thpnus
lrterus
Rerûainder (muscle)
GalI bladder
Heart
Total Body
Effeetive dose
Abs. fraction (g)
cafcs\DR 11cm cl-inicaf,ene
DR 11cm standard
270.0000
0.0000
5
Dose (nGy) :
0. 013096
0.009845
0.002429
0,006412
0.000s66
0.0r.6658
0.01-8530
0.012333
0.000000
0.000377
0. 000000
o . a28'79't
0. 005374
o . Q021,44
0.000001
0.004848
0.006848
0.01_8895
o.02325L
0 .00593 9
0. 00010s
0.016038
D.O07216
0. 0r.9032
0 . 000 666
0.006790
0.009860
6L.802495
109.0200
19.l_000
1
92.0000
21.0000
21.0000
0. 19L3
-99.4990
La.3294
15
20000
1.0000
1.0000
"74
4.5 ftn Al
0.0345
Errox (8) :
1- 6.3
17.8
1.1
0.9
5.6
)1
2.6
1.4
NA
2'1 .2
NA
4.8
l-. 4
23 ,4
80. 9?o
0.8
2.L
5.2
26.5
q.3
EA
8.6
v,¿
.PCXMC 1.5 - Dose values:
Datafl-].e: P:$¿asters\Dose calcs\DR 11cm clinical ha].f.ene
Header:proj ection:
Obl_. Angl-e:
Age:
Lenqth:
Mass:
Arms in phantorn:
FSD:
X-ray beam width:
X-ray beam height
Xfoeus:yfocus:
Zfocus:
NEIreVelS:
NPhOtS:
XYscale:
Zscale:
X-ray tube voftage (kV):
Eilter:
SurfDose:
Orqan:
Ovaries
Testes
Active bone marrow
Skeleton
Lungs
Lower large intestine
Stomaeh
Liver
Thyroid
Oesophagus
Breasts
Urinary bladder
Skin
Adrenals
Brain
Ki-dneys
Pancreas
Sma1l intèstine
Upper J.arqe intestíne
Spleen
Thymus
Uterus
Re¡nainder (muscle)
Gal-l bladder
Heatt
Total Body
Eff.ective dose
Abs. frâctj-on (i!)
DR lLcm standard
DoSe (mcy) :
0.006980
0.005247
0. 00129s
0.0034r-8
0.000302
0. 008878
o. 00987 6
0. 00 65?4
0. 000000
0.000201
0. 000000
0.015349
0.002864
0.001143
0 . 000 00r-
0.002584
0 .003 650
0 .01007L
0.012393
0.003165
0.000056
0. 008548
0.003846
0. 010144
0. 0003s5
0 . 003 619
0.00s255
61.8'02495
270. 0000
0.0000
5
109,0200
19. 1000
1
92.0000
21.0000
21.0000
0.191-3
-99.499Q
1.0,3294
15
2000Ò
1.0000
1.0000
70
4 .5 rnrn a1
0.01-84
Error (åJ :
l-6.3
1"7 .8
1.1
0.9
5.6
?a
2.6
1.4
NA
21 )
NA
4.8
1_.4
23.4
80.9?o
q?
0.8
2.7
5.2
26.5
't 
.7
0.3
5.0
8.6
4.2?n
PCXMC L.5 
- Dose values:
Datafile: P:,\Masters\Dose calcs\DR 11crn cliùical double.ene
Header:
Proj ection:
ôbl_, Anqle:
Ag€:
length:
Mass:
Arms in phantomr
ESD:
X-ray beam width:
X-ray be,am height
Xfocu$ i
Yfocus:
zfocus:
NEl,eveLs:
Nphots Í
Xyscì11_e:
.zscale I
X-ray tube voltage (kV):
Fil-ter:
SurfDose:
Organ:
ovaries
Testes
Active bone marror¿
Skeleton
Lungs
T,or¡¡e¡ large intestirre
Stomach
Liver
Thy¡oid
Oeso.¡rhagus
Breasts
Urinary bladder
Skin
Adrenal-s
Brain
Kidneys
pancreas
SmalJ- intestine
ïJpper larqe intestine
$Pleen
Thlanus
uterus
Remainder (Íruscle)
cal-1 b.Iadder
Heaxt
Total Body
Effective dose
Abs. fraction (t)
Dose (mGy) I
0.028585
0.02r,489
0 .00s303
0.013996
0.001235
0.036359
0.o44446
0.02692L
0.000000
o.000822
0.000000
0 ,0 6285 6
0.011731
0.004690
0. 000002
o 
" 
01-0581
0 .014948
0.041243
0.0507s2
0.012963
0.000229
0.03500?
0.0r.5752
a.a47542
0. 0014s4
0.0L4820
0 .021,522
61.802495
L lcir .standard
270, 0000
0,0000
5
109.0200
i-9.1000
1
92.0000
2r-.0000
21.0000
0.1913
-99. 4990
10.3294
l-5
20000
1.0000
1.0000
70
4,5 û[ A1
0.0753
Eüor (g) ¡
1 6.3,
17. I
l-.1-
0.9
trÁ
2.61t
NA
27.2
NA
4.8
t.4
23.4
80.9
3.9
5.?
0.8
2-r
qt
26.5
t.t
0.3
5.0
8.6
0,2
3.O
PCXMC 1.5 
- 
Definiti-ons:
Datafile: P:\Masters\Dose caÌcs\DR 16cm clinical.DEF
Header:
Proj ection:
Obl. Angle:
Age:
Length:
Mass:
Arms in phantom:
ren'
X-ray beam width:
X-ray beam height
Xref:yref:
Zrel:
NELeve].S:
NPhots:
DR 16cm clinical
270.0000
0.0000
fJ
1 63 . 9900
s4.5000
1
I 6. 0000
31.0000
31.0000
-0.8087
-8.9892
L6 .1L28
fJ
20000
PCXMC 1.5 
- 
Do-se values:
Datafi].e¡ P: \Masters\Dose calcs\DR 16cm elinical.ene
He.ader:proj ection:
Obl. Angte:
Age:
Length:
Mass:
Arras in phantom:
FSD:
X*ray beam widthr
X-ray beam height
.Xfocus I
Yfocus:
Zfocus:
NELeve].s:
NPhÖts:
XYscale:
Zscale:
X-r4y tube voltaqe (kV):
Filter:
SurfDose:
Organ l
ovaries
Testes
Active bone rnarrow
Skelêton
Lungs
Lower larEe intestine
Stomach
Liver
Thyroid
Oesophagus
Breasts
Urinary bfadder
skin
AdxenaLs
Braín
Kidneys
pancreas
Smal]. intestine
Upper large intestine
Spleen
ThFnus
Uterus
Remainder (muscle)
Gall_ bladder
Heart
TotaÌ Bod!¡
Effective dose
Abs. frãction (g)
DR 16cm standard
270.0000
0.0000
15
163.9900
54.5000
1
86.0000
31.0000
31.0000
-0.8087
-95.7892
l,6.'7 L28
15
20000
1.0000
l-. 0000
8l-
3.5 mm AI + O,l- mm Cu
0.2260
Dose (rnGy) :
0. L1_4158
0.030632
0 .0191-78
0.03902s
0,003262
0.1r-2930
0.136841-
0.074525
0.000064
0. 0017 68
0.001-634
a.212A4t
0.037500
0.011-489
0.000001
0 . 033 917
0.048772
0.l_38r65
0.160897
0 .037375
0 .000s19
0.141,24A
0.051_256
0 .1 60866
0 .004988
0.048976
0.068249
62.199467
Effor(%) :
i.1-.1
13 .3
1,1
0.8
6,9
¿.1
3.0
1".4
100.0
32.8
1a a
-J- l
1)
18.3
100.0
QO
6.0
1)
aa
4.6
q? /
r.)
0.2
4.6
z-t
PCXMC 1.5 
- Dose val-ues:
Datafil-e: P;\Masters\Dose calcs\DR 16cm clinical. half.ene
Header:
Projection:
Obl, Angle:
Age:
Length:
Mass:
Arms in phantom:
FSD:
X-ray beam width:
X-ray bean height
Xfocus:
Yfocus:
Z focus :
NELevels:
NPhots:
XYscal-e:
Zscale:
X-xal¡ tube voltage (kV) :
Fi.lter:
SurfDose:
Organ:
Ovaries
Testes
Active bone marrow
Ske].eton
LuRg.s
Lower l-arge intestine
Stomach
tiver
Thyr.oid
Oesophagus
Breâsts
Urinary bJ.adder'
sklrl
Adrenals
Brain
Kidneys
pancreas
gmal-I intestine
Upper l-arqe inlestine
Spleen
Thymus
üterus
Remainder (muscle)
Ga1l bladder
Heart
Total Body
Effective dose
Abs. fraction (B)
DR L6cm standard
270.0000
0.0000
15
163.9900
54.5000
1
86.0000
31. 0000
31.0000
-0.8087
-95.7892
16.7728
15
20000
1.0000
1-.0000
81
3,5 run A1 + 0. 1 ffifr Cu
a.L721
Dose(mcy): Error(e):0.056637 11.10.0151-97 13.30.009514 1.10.01936L 0.80.001618 6.9
0. 056027 2.10.067890 3.00.036974 1.4
0. 000032 100.00.000877 32.80.000811- 33.3
0. 105199 3.1-0.018605 L.20.005700 18.30.000000 100.0
0. 016827 3. 90.0241"97 6.00.068547 L.20.0?9825 2.30.018543 4.60.0002s8 53.40.070073 4.20.025430 0.2
0 .079809 4 .60.002475 8.50.024298 0.20.033860 2.2
62.r99467
PCXMC 1.5 
- 
Dose val-ues:
Datafiler P:\Masters\Dese calcs\DR t6cm clinica]. double.ene
lieader:
Proj ectiol::
ObJ.. Angle:
Aqe:
Length:
Mass:
Arms in phantom:
ESD:
X-ray beam width:.
X-ray beam height
Xfocus:
Yfocus:
zfocus:
litrELeve].s:
NPhots:
XYscale:
Zscale:
X-ral. tube voltage (kV):
Filter:
SurfDose:
Orqan:
Ovâries
Testes
Aetive bone marrow
Skeleton
Lunqs
Lohrer large intestine
stomaeh
tiver
Thyroíd
Oesophag,us
Breasts
Urinary blad.der
SkÍn
Adrenals
Brain
Kidneys
PâNCIEAS
Smal1 Lntestine
Upper l-arge intestine
SPleen
Thlmus
Uterus
Remainder (muscl-e)
Gal]. bladder
Heart
Total Body
Effêctive dose
Abs. fraction (å)
DR 16cm standa¡d
270 .0000
0.0000
15
1 63 . 9900
54 .5000
1
86,0000
31 .0000
3l-.0000
-0.808?
-95.7892
16.7L28
15
20000
l-.0000
t-.0000
8l-
3,5 mn AI + 0.1 nun Cu
Dose {mGy} :
a,223892
0.060077
0 .03'7 612
0.076538
0.006397
0.221483
4.268378
0. r.46r.61
0.000125
0. 003467
0.003204
0.415864
0,073547
0.022532
0.000002
0. 066518
0.095653
0;2'70975
0.3r-5s58
0.07330L
0.001-0i-8
0.271006
0.l-00526
0.315496
0.009782
0.096053
0. 133853
62.79946'7
0.4433
Error(å):
11.1
r-3 .3
L.1
0.8
6.9
2."7
3.0
L.4
100.0
32.€
33 .3
3.1
L.2
L8 .3
10û.0
3,9
o.u
L,2
)?
4.6
53.4
4.2(\)
4.6
8.5
0.2
2.2
PCXMC 1.5 
- Definitions:
Datafrfe : p: \Mastel:s\Dose caÌcs\CR
¡IeaCer:
Proj ection:
Obf. Angle:
Age:
Length:
MâSS:
Arms in phantom:
F'SD:
X-ray beam width:
X*ray beam height
Xref:yref:
Zref:
NELevefs:
NPhOtS :
6cm clinical 
. DEF
CR 6cnì Clinical
270.0000
0.0000
I
7 4 .9600
9.3600
I
91.0000
16. 0000
r6. 0000
-0.1519
_5. 6990
8.5071
l5
20000
ÞCXMC 1.5 
- DOse vâLuês:
D.atäfile: F:\Masters\Dose calcs\CR 6cí1 clini.ca-i..ene
lleader:
PËôj ection :
Obl. Angfe:
Aqe:
L€ngth:
Màs€:
Aûns ia phantom:
FSD!
k-ray beam r¡tdth:
X-ral¡ beam height
Xfôcus:
Yfoeus:
.z focus:
NEl,eveIs:
NPhots:
XYscaIe:
?sca.Le:X-ray tube volt.a.ç.e fkv):
Filter:
SurfÞose:
0rgan:
Ovaries.
Têstes
Active b-one marroïr
6keleton
Lunqs
Lor,Jer large intestine
S tomach
tiver
Thyrald
Oesô¡rhâgus
B¡eêste
IJrinary bladder
Ski¡l
Adrenê1s
Brain
Ki-dneys
Pancreas
S¡nal1 intestine
'itpper larqe intestiûe
Spleen
Thlrmr¡s
U te rus
Re¡nalnder {mu.scle)
Ga11 bladder
HéãTt
Total lltody
Effective dose
Abs. fr¿ction (å)
CR 6cm Cl-inicaL
2?0. 000d
0. û000
1.
14.9600
L 3600
1
91. 0000
16.000ó
16.0000
-0.1519
97.499A
I .50?i.
t5
20000
1.0000
1 .0000
58
2.S rûrn A1
0.04 0.3
Dose (mcyl : Error (å) :0.013113 L6,2
0 . 002'151 26 . O0.00r_584 0.Ë0-0065'83 0.8û.0006,46 4.50.01289€ 4. s0.018905 3.60.0133L2 1. L0'00û000 NA0.0003t5 26,L0.00002's l-0û.00.024058 3.9
0. 005971 1 .5q.002213 2L.3
0 
- 00000? 5? . I0.004068 3 
" 
90.008815 6-70.0r-5245 1.30.0r€808 3.30.00s599 6.6
0. 110ü160 25.5
0. 016?26 L1 
- 
g
0.006638 a.2
. 0,017547 5 .2
0 
" 
000985 6. 9
0 .Qû6191 0.10.008389 3.0
.6?.31507.9
PCXI.IC 1,5 
- Dose values:
Datafile: p:\Masters\Dose calcs\CR 6cm cLinical Double.ene
HeadeÎ:proj ec Lion :
Obl. Anqil-e:
ÀEe:
Length:
MâSS:
Arms in phantom:
FSD:
X-ray beam width:
X-ray bêam height
Xfocus:
Yfocìrs:
Zfocus:
NELeveIs:
NPhots:
XYscal-e:
zscafe 1
X-ray tubê voftag'e (kV):
Filter:
SurfDose:
Organ.:
OvarÍes
Testes
Active bone marrow
Ske.l-eton
tunqs
Lower large intestine
Stomach
Liver
Thyroid
Oesophagus
Breasts
Urinary b.Ladder
Skin
Adtena]-s
Br'ain
Kídneys
Pancreas
Small intestine
Upper lar.qe intêstine
Spleen
Thymus
Ulerus
Remaj-nder (muscle)
Gall- bladder
Heart
Totat Body
Effective dose
Abs. fraction (%)
CR 6cm Ci-inical-
270 .0000
0.0000
1
74.9600
9.3600
1-
91.0000
16.0000
l-6.0000
-0.r519
_9.7.4990
B.50lL
15
20000
1.0000
1.0000
5B
2.5 ruR A1
0.0815
Dose(mcy): Error(%):0.026511 L6.2
0. 005574 26.A
0. 003202 0. B0.013309 0.80.001305 4.50.02607'7 4.5
a -û3e220 3 .60.026913 1.10.000000 NA
0 - ao1'777 26 . L0.000050 100 . û
0 .048 639 3 .90.012071 l-.50.004414 2L.30.000004 s7.8
o.00822s 3.90.017821 6 -70.03,û822 1.30.03s024 3.30.011319 6.60.0.00323 25 .50.03381-6 11.80.013420 0.20.035475 5.2
0" 001992 6.90.0L2516 0.10.016961 3.0
67 .315079
PCXMC 1.5 
- Dose va.Iues:
Datafile: p:\Maeters\Dose calcs\CR 6cm
Ileader:proj ection:
Obl. Angte:
ÄEe:
Length:.
Ma,sS:
Arms in phantom:
FSD:
X-r.ay beam width:
X-rây bêam height
Xfocus:yfocus:
Zfocus:
NELevefs:
NPhots:
Xyscale:
Z s cêle.:X-ray tube vol-taqe (l<V) :
Filter:
SurfDose:
Orqan:
Ovaries
Testes
Active 
.bonè rna¡r'ow
Skeleton
Lungis
l,ower J-arge in tes Line
SLomach
tiver
rhyroid
eesçphagus
Ereasts
Urinary bLadder
Skin
Ad¡enå1s
Bral-n
Kidneys
PancreasSnafl i.ntestine
Upper Large intestine
Spl_e.en
Thyrnus
Uterus
Rê¡nainder (muscle)
cafl blåd.der
Heart
Total, Body
Effective dose
l\bs, fraction (%)
Ðose (mGy) :
0.00627L
0.001319
0.000757
0.003148
0 .000309
0.006169
0.009041
0.006367
0. 000000
0.0001-84
0.000Õ12
0.011506
0.002855
0.001058
0.000Õ01
0.001946
a.Ða4216
0.00-t291
0.008995
a.ñ2678
0.0t0016
0,007999
0.003175
0.008392
0.000471
0.002961
0.004012
6?.3150?9
clinicaf Hâlf,.ene
CR 6crfl Clinical
270.0000
0.0000
1
7 4 ,960t
9.3600
1
91 .0000
16.0000
16.00ó0
-0. 1519
-97.4990
8.50?t_
15
20000
1.0000
L. 0000
to
2.5 run Al
0.01-93
Error(å):
16.2
26.4
0.8
0.8
4.5
4.5
3.6
1,1
NA
26.L
100.0
3.9
'tq
2L.3È? o
?q
6. t
1,. 3
3.3
6.6
tq q
11.8
ta
6.9
0,1
3.0
PCXMC 1.5 
- Definiii.ins:
Dataftle : P: \Masters\Dose calcs\CR 1lcm clinical.DEF
Header:
Pro j ect.ion:
Ob1. Angle:
Age:
Length:
Nlas s :
Arms in phânton:
X-ray beam wicith:
X-ray beam height
Xref:
Yref:
zrel:
NELeVeIS:
NPhÕts:
CR 11cm clrnicaf
270.0000
0.0000
5
109.0200
19. 1000
I
86.0000
21.0000
21.0000
0. 0000
0.0000
10.0000
15
20000
PCXMC 1.5 - Dose values:
Datafil-e: P: \Masters\Dose calcs\CR lLcm clinical.ene
Header:
Proj ection:
Obl. Ang1e:
.ê,ge I
Lenqth!
Mass:
Arms in phantom:
FSD:
X-ray bearn width:
X-ray beam height
Xfocus:yfocus:
Zfocus:
NEl,evels:
NPhots:
XYsca]"e:
Zscale:
X-ray tube vol-tage (kV):
Filter:
SurfDose:
Organ:
Ovaries
Testes
Active bone marrow
Skeleton
Lungs
Lower l-arge intestine
Stonach
Liver
Thyroid
Oesophagus
Breasts
Urinary bladder
Skin
Adxenalg
Brain
Kidneys
F.ancreas
SmaJ_l intestlne
Upper l-arge intestine
Sple.en
rhymus
Ilterus
Remainder (muscle)
Ga11 b.l-adder
Heart
TotaL Bôdy
Effective dose
Abs. fraction (å)
Dose (mcy) :
0.025849
0.047981
0.003519
o.010502
0.000736
o.o2'1269
0.030337
0.021r.s7
0.0û0000
0.00839r
0.000245
0.0so080
0.01-2880
4.D02L42
0.000000
0.007064
0.009234
0.031814
0.Q38627
0.008323
0.0001,38
0.029963
0. 0134 95
0.035183
0.000846
0. 012391
0 . Õ2004 r
68.328905
1l-cni cÌinical-
270. 0000
0.0000
5
109.0200
19,1000
1
86.0000
2r-.0000
21.0000
-0.0000
-93.5000
10.0000
15
20000
l. 0000
1.0000
6Z
2.5 rur AÌ
0.08s8
error (8) :
L3 .4
13 .0
1.0
0.9
6.3
3.6
3.1
1q
90.4
?? c
100.0
4.6
L.Z
24.3
96.6
3.8
1.7
1A
2-S
5.0
4û.3
1A 1
0,2
4.6
8.2
o.2
11
PCXMC 1.5 
- Dose val-ues:
Datafile: p: \Masters\Dose
Header:proj ection :
Obl-. Angl-e:
Age:
Length;
!4as s :
Arms in phantom:
FSD:
X-ray b¡eam width:
X-rày bean hei.ght
Xfocus:yfocus:
zfocus I
NEl,e\¡e1s:
Npì1ots:
XYscalê:
zscale lX-ray tube voltage (kV):
Fl--Lter:
SurfDose:
Orqân:
Ovaries
Testes
Active bone marrülr
Skeleton
tunqs
Loh¡er l_arge intestine
Stômach
Live¡
Thyroid
Oesophagus
Breasts
Urinary bladder
Skin
Adrenals
Brain
Kidneys
pancreas
Small lntestine
Upper large intestine
Spleen
Thymus
Uterus
Renainder (musc.l-e)
call bIädder
I{ea¡t
Total Body
Effective dose
Abs. frâction (*)
calcs\CR 1lcm
CR llcm
cLinica]- Ha]f . ene
clinicâl Double
270.0000
0.0000
5
109.0200
19.l-000
I
86.0000
21.00Õ0
2i".0000
-0.0000
-93 .5000
t-0.0000
15
20000
1.0000
1.0000
62
2.5 m At
0.0420
Error(B):
11 ¿
13.0
r.0
0.9
6.3
3.6
3.1
1r
90.4
l? Ã
100 .0
4.6
L.2
24.3
96 .6
3.8
7.I
r.4
,o
5.0
40.3
1A 1
0.2
4.6
0.2
Dose (m6y) :
0. 0t-2661"
0.023501
0.ao7124
0.005144
0. 000360
0.013356
0.0r"4859
0.01_0363
0.000000
0.000192
0.0001"20
o.024529
0.006308
0.001049
0.000000
0. 003460
0.004s23
0. 01558t3
0.0r.8916
0.004076
0.000068
0.014676
0.006610
0 .01r233
0 .000414
0.006069
0 .00981 6
68.328905
PCXMC i-.5 - Dose vaLues:
Datafile: P:\Masters\Dose cal-cs\CR lLcm elinical Doublê.erie
Heedet;
Proj ection:
Ob].. Angle:
Age:
Length:
Mass:
Arms in phantoÍr:
F.SD:
X-ray beam r¿idth:
x-ta]¡ b€,am height
Xfocus:
yfocus i
Zfoeus ¡
NELevels:
NPhots:
XYsc'ale;
Zsca1e:
X-¡:ay tube voltage (kV):
Filte r:
SurfDose:
Organ:
Ovaries
Testes
A,ctive þone rnaffow
Skel.eton
l,unqis
Lower farge intestine
Stomaeh
Lí¡¡e r
tthyroid
Oesophagus
Breãsts
Urinêry bladde¡
Skin
AdrenaLs
Brain
KJ"dneys
Paûcteas
Smalf intestine
Upper large intestine
Spleen
Thymus
ûterus
RemaiÞder {muscle)
Gal1 bladder
Heart
Totäl Body.
Ef,fectl_ve dose
Abs . f raction (e" )
CR 11cm e1i-nical Double
Dose (.r,lcy) I
0.0r51-435
a.0954"12
0. 007002
0.02089?
0.001464
0-054260
0.060365
.0.042098
0 .0û0001
0.000778
0 .00048?
0.099649
0.025629
Õ.a04263
8.000r00
0.0L405?
0.018375
0 ,063304
0.076848
0. .016560
0. t002?4
0.059620
0. 02 6853
o . 070008
0 .00168'3
0.û24655
0 .039878
68 .328905
270 
- 0000
0.00,00
5
109, Q200
t-s.1000
t-
86.0000
21.0000
21.0000
-0. 0000
-93.5000
l0.0000
r5
20000
1.000ü
l- ,0000
62
¿.5 mm AI
0, 170s
Error (å) .:
13.4.
13. 0
1.0
0.9
o.J
3." I
l-. 5
90. 4
37.5
100.0
4.6
1)
2A 1
96.6
3,8
7.1"
1.4)c
5.0
40.3
1"4.7
^av.14.6
8.2
,0.2
PCXMC 1.5 - Definitions:
Datafile: p:\Masters\Dose ca.lcs\CR 16cm clinical.DEF
Header:
Proj ectlon:
Obl. Angle:
Age:
Length:
IUass:
Arrns in phantom:
FSD:
X-r:ay beam wldth:
X-ray beam height
Xref:
Yref:
zTef i
NELeveIs:
Nphots:
CR 16crû clinical
270. 0000
0. 0000
15
t_ 63. 9900
54.5000
l
77.0000
31.0000
31.0000
-0. 8087
-e .9892
t6.lI2B
15
20000
PCXMC 1.5 
- Dos.e va.Lues:
Datafile: p:\Masters\Dose calcs\CR l6cn cfin.ical.ene
Header:
D-^i À^t 'E!uJcuL].On:
Obl . AngJ_e:
Age:
Lenqth:
Mass !
Arms in phantom:
FSD:
X-ray beam width:
X-ray þeam heiqht
Xfocus:yfocus:
Zfocus:
NELeVe}S !
Nphots:
XY.SÕaÌe:
Zsca1e:
X-ray tube voJ_tage (kV):
Fil Ler:
SurfDose:
Organ:
Ovaries
Testes
Active bone marrow
Skel-eton
Lungs
Lower largè intestine
Stomach
Liver
Thyroid
Oesophag:us
Breasts
ürinary bfadder
Skin
Adrenals
Brain
Kidneys
Fancreas
Sma1l lntestine
Upper l_arge intestine
SpÌeen
Th]¡mus
Uterus
Remainder (nusc].e)
Galf bladder
TTeaTI
Total Body
Effective dose
Abs. fraction (å)
CR 16cm clinical
270.0000
0.0000
15
1 63 . 9900
54 .5000
1
77.0000
31.0000
31.0000
-0..8087
-86.7892
L6.11,28
¿J
2000 0
1.0000
1.0000
.10
2.5 nrn A1 + 0.0b m¡n Hf
0.2610
Dose (nGy) :
0.109?31
0.03s590
0.a17722
0.039787
0.003204
0.1099s0
0. 139780
0.07'7295
0. 000040
0. û01333
0. 001235
0.223859
0..041157
0.01 1073
0. 000000
0.030061
0. û54820
0. r40001
0.1?031?
0,039612
0.000415
0.L45542
û. 053578
0. r59030
4.004'123
0.050974
0.069804
65 .424943
Error(å):
1t I
L4.'1
0.9
0.8
6.1
4.0
3.3I.7
100.0
32-6ÊÈ â
a-l
1.2
25.2
NA
4.5
5.4
1.5
,l
1q
s4.3
0.3
4.0
r.0.7
o,2
PCXMC 1.5 - Dose values:
Datafile: P: \Masters\Dose
Header !
Dr^i ô^l
- - 
_J __ E1On:
OLìt. Angl-e:
AEe:
Length:
MaBs:
Arms in phantom:
FSD r
X-ray beam $ridth:
X-ray beam hèight
Xfocus:yfocus:
Zfocus:
NEL.evels:
NPhots:
XYsca1e:
Zscafe:
X-Ìay tube vol-tage (kV):
Eilter:
SurfDose:
orqan:
Ovaries
Testes
Active bonê marrohr
Skeleton
Lunqs
Lower larqe i-ntestine
Stomach
Liver
Thyroid
Oesophagus
Bxeasts
Urinary bladder
Skin
Adrena.Is
Brai-n
Kidneys
Pancreas
Smafl intesti-ne
Upper large inteslj-ne
Spleen
Thlrmus
Uterus
Remainder (muscle)
Gall bladder
Heart
Total Body
Bffective dose
Abs. fraction (%)
calcs\CR 16cm clinical double.ene
cR l-6Òilr cl-inical
270.0000
0.0000
1Ã
163.9900
s4.5000
1
77 .0000
31,.0000
31.0000
-0.8087
-86,1892
L6.7r28
l-5
200Õ0
L .0000
t-.0000
7A
2.5 mm Al + 0.05 rûm I{f
0.469s
Dose (¡nGy) :
0 . r-973 69
0.064014
0.031876
0.071s63
0.005762
0 . 1977 63
a.25L4L't
0. l-39028
0.000073
0.002398
o.00222L
a .442645
o.07 4021
0.019917
0.000000
0.054069
0.098602
0.2518t-4
0.306334
0.071_356
0.000746
0.2617€0
0.096369
o.30402'1
0.00849s
o .091 684
0 . 12555 4
65.424q43
Error (Íà ) :
L2.4
14.7
nq
0.8
6.L
4.0
3.3
r.7
100.0
32 .6
qq ?
q)
t.¿
z3-z
NA
^q5.4
1.5
2 .1,
?q
EA A
J5 ! J
4.8
0.3
4.0
10.7
t.2
2.4
PCXMÇ 1.5 - Dose values:
Datafife; P: \Masters\Dose
Header:
Proj ection:
Obf. Ang1e:
Aqe:
Length:
MâSs:
Arms in phantÒm:
FSD:
X-ray beam width:
X-ray beam height
Xfoctls:yfocus:
Z focus:
NELevélS:
Nphots:
Xyscale:
Zscale:
X-ray tube voltage (kV):
Fit_ter:
Sur'fDos,e:
Organ:
Ov-aries
Testes
AcLive bone marfow
Skefeton
Lungs
LoI^Ier larqe intestine
StonaCh
Liver
Thyroid
Oesophagus
Breasts
Urinary bladder
Skin
Adlenal,s
Brain
Kidneys
pancre€.s
Snal_I intestine
Itpper large intestine
Sple'en.
Thymus
Uterus
Remainder (muscle)
Gall bladder
Eeart
Totaf Body
Effective dose
.Abs. f racti-on (g )
calcs\CR 16cn cLj-nical" half.enê
CR 16cm cl-ifiic.al
2?0.0000
0.0000
t-5
163.9900
54 .5000
1
77.0000
3r. .0000
31 .0000
-0.8087
-86.7892
76.7L28
1q
20Ò00
1.0000
1.0000
70
2.5 mm A1 + 0,05 rnÍri Hf
0 
- 
1086
Dose (mcy) :
0. 045660
0.014809
0.007374
0.016556
0.001333
0.045751
0.058r"64
0.032163
0. 000017
0.000555
0.000514
0 . 09314 9
o.0I7L26
0.004608
0. 000000
0.0r2509
a . Q228LL
0.058255
0.070868
0.016508
0 
" 
000173
0 . 060s 61
o.Q22294
0. 0?0335
0,00r965
o.a2r2LL
L429046
65 ,4249.43
Error(8);
1) A
1A'1
0.9
0,8
4.0
a?
1.7
l-00.0
32 .6
55.3
q)
1.2)c t
NA
aq
q,^
1q
2.r
-q
54.3
4.8
n?
4.0
rt.7
2-4
PCXMC 1.5 
- Definitions:
Datafile: P: \Masters\Dose
Header:
Proj ection:
Obf. Angfe:À^â.
.¡vu I
Length:
Mass:
Arms .in phantom:
FSD:
X-ray beam width:
X-ray beam height
Yrôf '
VF^f.
Zref:
NELeVefS:
NPhots:
calcs\DR 6cm dose comparison.DEF
DR 6cm dose comparison
270.0000
0.0000
1
1 4 .9600
9.3600
I
97.0000
16.0000
16.0000
-0.1519
-5 . 6990
I .5071
15
20000
PCXMC 1.5 
- 
.Dose \ralues:
DatafiLe: P:\l¡asters\Dose câl_cs\DR 6cm dose con¡parison,ene
DR 6cm Standard
270 ,0000
0 .0000
1
"7 4 .96A0
9.3600
t-
97.0000
16.0000
16.0000
_0.1519
_1"03.4990
I .5071
15
20000
l-.0000
1.0000
3
3.5 mn A1 + 0.2 mm Cu
0 .0066
Heâder:
Proj ection :
Obl, Anqte:
Age;
Length:
Mass:
Arms in phantom:
FSD:
X-ray bean width:
X-ray beam height
Xfocus:yfocus:
Zfocus:
NELevel_s I
Nphots:
XYscal_e I
Zscal-e:
X-ray tub.e voltage (kV) r
Filter r
SurfDose:
Organ i
Ovaries
Testes
Actíve bone marrow
Skeleton
l,ungs
Lo¡¡er ]-arg.e intestin€
Stomach
Liver
Thyroid
Oesophagus
Brêasts
Urinary bladder
Skin
Adrena].s
Brain
Kidreys
pancreas
S¡nalL int.estine
Uppér large intestine
spleen
Thlmus
Uteru$
Remainder (rnuscle)
cal_l- bLadder
Heaxt
Total_ Body
Effective dose
Aþs, fractj-on (*)
Dose (mcy) :
0. 004067
0.001r,87
0,000568
a.002123
0.000259
0.004187
0,004923
0.003 659
0.000000
0 . 000 172
0.000047
0.006s98
0.00r-L40
0.000865
0.000001
0.0'01-526
0.002843
0.004871_
0.005570
0.00r-988
0.000076
0.005456
Õ.001,772
0.005245
0.000364
0.001-708
0.002450
55 .697521
Enor{*):
L7 .L
22.5
L.0
0.8
4.0
?1
7-2
NA
2t.9
98. 1
J.¿
10
1a 1
4 6.8
?1
7.7
I-2
3.0
4.4
24.1"
L¿,V
0.3
o.¿
6.4
^a
PCXMC 1.5 
- Definitions:
Datafile: P: \Masters\Dose
Header:
Proj ection:
Obl . Angl-e:
Age:
Length:
Mass:
Arms in phantom:
rQn.
X-ray beam width;
X-ray beam height
Xref:yref:
zref:
NELevel-s:
NPhots:
calcs\DR 11cm dose
DR l-1cm dose
comparisona, DEF
comparison
270.0000
0.0000
5
109.0200
19. 1000
1
92.0000
21.0000
21.0000
0.1913
-6.6990
1"0.3294
15
20000
PCXMC L.5 - Dose valuesl
Datafile: P:\Masters\Dose calcs\DR 11cm dose comparison.ene
Header:
Proj ection:
ObI. Angle:
Aqe:
Length:
Mass i
Arms. in phantom:
FSD 3
X-ray beam t¡idth:
x-ray beam height
Xfocus:
yfocrxs:
Zfocus ¡
NELevel-s:
Nphots:
Xyscale:
zscale..
X-ray tube voltage (kV):
Filter:
SurfDose:
Organ:
Ovaries
Testes
Active bone marrow
Skeleton
Lungs
Lor4¡er ].arg.e intestine
Stomach
T.iver
Thyroid
Oesophagus
Breasts
Urinaty bladder
skin
Adrena].s
Brain
Kidney.s
Pancreas
Smal1 intestine
Upper large intestine
Spleen
Thl¡mus.
Uterus
Remainder (muscle)
call bladder
Heart
Total Body
Effective dose
Abs. fracti-on (8)
DR LLcm standard
270.0000
û.0000
5
l-09.0200
19.1000
L
92.0000
21.0000
21.0000
0. l-913
-99,4994
1^ aao¡
15
20000
1 .0000
1.0000
70
3,5 ffn A1 + 0,2 mm Cu
0.0254
Dosè (mcy) :
0.013150
0.008462
0.002667
0.006585
0.000658
4.077265
0 . Õ1,'7 223
0 . 0118 63
0.000000
0.000424
0. 000000
0.027505
0.004353
0.002501
0.00Q001
0. 005339
0 . aû1246
0. 0192r-0
0.023343
0" 006389
0. 000135
0.016781
0.006766
0.0r-9092
Ò. 000?4?
0.006479
0.009s34
56.9A9412
Error (g) :
'J,6.2
21 .9
l-.1
0.9
5.6
z,Y
¿,I
1.5
NÃ.
26,0
NA
1.3
23.0
'78.7
?q
RI
0.9
2.0
5.0
26.5
'7 
.6
0.3
4.9
8.5
4.2
3.1
PCXMC 1.5 
- Definitions:
Datafile: p:\Masters\Dose calcs\DR l6cm dose comparison.DEF
Header:
Proj ectíon:
Obl . Angl-e:
Age:
Length:
Mass:
Arms in phantom:
FSD:
X-ray beam width:
X-ray beam height
Xref:
Yref:
Zref i
NELevefs:
Nphots:
DR 16cm dose comparison
270.0000
0.0000
15
163.9900
s4 . s000
1
86.0000
31.0000
31.0000
-0.8087
-8.9892
L6.7L28
15
20000
PCXMC l-.5 
- 
Dose values:
DatafiLe: P¡\Masters\Dose cal_c$\DR j-6cm dose comparisonl-.ene
DR 16cm dos.e comparison
2?0.0000
0.0000
L5
163. 9900
54.5000
1
86- 0000
31.0000
31. 0000
_û.808?
_95.7892
L6.'11,28
15
20000
1.00û0
l_.0000
8l-3,5 mm A1 + 0,2 mm Cu
Header:proj ection:
ObI . Ang'te:
Age:
Length;
Mass:
Arms in phantom!
rsD:
X-ray beam wldth:.
X-ray beam hei-ght
Xfocus:
Yfocus:
.Zfocus:
NEIJevels:
Nphots:
XYscale:
Zacale:
X-ray tube vol-tage (kV):
Fil_ter I
SurfDose:
Organ:
ovaries
Testes
Active bone marrow
Skel-eton
Lungs
Lo$¡er large intestine
Stomach
Liver
Thyroid
Oesophagus
Breasts
Urinary bLadder
Skin
Adrena].s
Brai-n
Kidneys
Pancrêas
SmalL intes.tine
upper large intestine
spl-een
Th!¡mus
Utefus
Remainder (muscl-e)
Gal_l b].adder
Heart
Tota]. Body
Effectíve dose
Abs. fraction (t)
Dosê (ûrcy) r
0.070501
0.0l-8745
o.ar2t20
0.023688
a.aa2092
0.068784
0.081330
0. 04 4601
0.000047
0.o07t21
0.001061
a.-J.26Õ7'1
0.020563
0.00?128
0.000001
0.021566
0.030074
0.083984
0.096874
Q.023288
0.000359
0 
" 
0849L9
4.029986
0 . Õ957 25
0.003228
0.02883s
0.041150
60.41,2223
0.1 183
Error (t) :
11.l-
t-3. 1
1. l-
0.7
7.O
1A
3.0
1.5
r.00.0
32.6
?? o
aa
L.2
18.0
100.0
?q
qq
1.3
t?
4.7
53.3
4,2
0.2
t4
ñ)
2.2
11. Appendix2- Raw lmage Group Data and Ghi-Square
Results under Standard Gonditions
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6cm Opt¡m¡sed Dose
6
56
56
653
436
266
0636
131466
000455666
0000'1 0155
000000400
000000000
000000000
000000000
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Raw lmage Group Data and Chi-Square
Results under Glinical Gonditions
Page 138
6cm Optimised Dose
1.3 1.6
CR
6
5
0
0
0
0
6
5
0
0
0
0
6
1
4
0
0
0
6
5
0
0
0
0
0
6
5
1
0
0
0
0
6
4
4
0
0
0
0
0
6
3
6
6
3
1
0
0
0
0
0
0
6
6
5
3
6
6
3
0
0
0
0
0
0
6
5
5
6
4
2
0
1
0
0
0
0
0
0
1
2
1
4
6
0
4
0
0
0
0
0
0
0
0
2
1
3
2
3
0
0
0
0
0
0
0
0
0
1
0
2
1
1
5
0
3
1
0
0
0
0
0
0
1
1
1
6
0
0
4
2
0
0
0
0
0
0
0
0
o
0
0
2
1
0
0
0
0
0
0
0
6
66
1466
0103666
0000010
0000000
0000000
0000000
10166
01426
201456
0013556
0035346
1000146
1010014
0010026
0000001
0000000
0000000
0000000
0000000
0000000
Totals grouped in pa¡rs, except for shallowest holes which are grouped to the 3 shallowest depths
Chi sq = 17.35d'f 6
DR
r l l
23
CR
rcet
38
32
70
39
23
22
17
57
51
24
15
13
13
0.00808650p<
6cm Half Dose
1.3 1.6
CR
DR
CR DR
Totals grouped in pairs, except for shallowest holes which are grouped to the 3 shallowest depths
Chi sq = 18.36df6
47 13
42 40
62 5123 2617 23
13
13
15
12
o22126
616
156
0446600010660000100000000000000000000000
001036
6050666063562500560362000436
01310340310002000000400000000000000000000000000000000000
6
4
66
446
1346
003566
00015366
00000000
00000000
00000000
00000000
012066
001255
400136
001166
001303000022100002001000000000000000000000000000000000000000
0.00538427p<
11
b
6
56
6666
151566
000464666
010000114
000000000
000000202
000000000
15566
04246
64646
06566
01665
63406
65601
05601
02002
00100
00000
00000
00000
00000
CR 6cm Double Dose
1.3 6.31.60.80.60.50.40.3 2.5 3-2
6.
9q
2
1.6
1.3
1
0.8
0.6
0.5
0"4
0.3
CR DR
ïotals grouped in pairs, except for shallowest holes which are grouped to the 3 shallowest depths106 52
75 5942 3222 1822 17
16 14
Chi sq = 5.70df6
5
5
2
4
0
0
0
1
0
0
0
0
0
0
0
6
6
46
366
01366
000356666
000000103
000000000
000000100
000000000
66456
365
466455016002000000000000000
000000
1
0
2
0
1
4
0
0
0
0
0
0
0
0
0.45739162p<
22 16
11cm Optimised Dose
1.3 1.6
6
5
1
0
0
0
6
0
0
0
0
6
0
0
0
0
0
6
6
2
0
0
0
0
0
6
5
5
4
3
0
0
0
0
6
6
5
5
2
0
0
0
0
0
5
6
6
5
6
1
1
0
0
0
0
0
0
6
5
3
4
4
5
5
4
1
0
0
0
0
0
6
5
3
4
2
3
0
0
2
0
0
0
0
0
0
4
4
0
1
4
3
5
1
0
1
0
0
0
0
0
0
1
1
4
4
0
0
0
0
0
0
0
0
0
0
0
1
0
4
0
2
2
0
0
0
0
0
0
0
0
0
2
0
0
2
0
0
0
0
0
0
0
0
0
6
0
0
5
4
0
0
0
0
0
0
0
1
6
5
0
0
0
0
6
0
0
0
0
6
0
0
0
0
1
6
1
1
0
0
0
0
6
2
0
0
0
0
0
6
6
2
3
0
0
0
0
0
6
6
6
5
4
3
0
0
0
0
0
0
6
5
5
4
4
0
1
0
0
0
0
0
0
6
4
6
2
1
1
3
1
0
0
0
0
0
0
3
2
1
5
0
2
0
0
0
0
0
0
0
0
2
0
1
1
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
5
0
0
3
0
0
0
0
0
0
0
0
DR
Totals grouped in pairs, except for shallowest holes which are grouped to the 3 shallowest depths9 Chi sq = 12.2324df6
55 p<
47
16
13
CR
t
28
35
62
54
37
12
0.05707333
21 22
11cm Half Dose
1.3 1.6
CR
00011436001030336
5000042656010142245600030125656
50001034566
210011502456
00100210156601001000133566
1000000000005200000000000000000000000000000000000000000000000000000000
6
4
0
0
0
0
6
2
0
0
0
0
6
5
1
0
0
0
0
6
2
0
0
0
0
0
6
6
2
4
0
0
0
0
0
6
6
4
3
3
0
0
0
0
0
0
6
6
3
6
1
4
3
0
0
0
0
0
0
6
5
4
2
1
2
1
0
0
0
0
0
0
0
4
0
6
2
0
1
1
0
0
0
0
0
0
0
2
2
1
6
0
0
0
0
0
0
0
0
0
0
0
0
,|
0
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
1
0
1
0
0
0
1
1
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
4
CR ÐR
Totals grouped in pairs, except for shallowest holes which are grouped to the 3 shallowest depths
18
20
44
59
61
28
14
9
18
41
51
26
20
20
Chi sq = 12.39
df6
0.05389857p<
11cm Double DoseCR
6
0
0
0
0
6
1
1
0
0
0
6
2
0
0
0
0
6
3
I
0
0
0
0
6
3
3
3
0
0
0
0
6
6
6
3
2
0
0
0
0
0
0
6
6
6
4
6
6
6
4
3
0
0
0
0
0
5
6
6
3
3
6
3
3
2
0
0
0
0
0
5
5
4
6
1
6
1
0
2
0
0
0
0
0
4
2
3
5
6
0
0
0
0
0
0
0
0
0
1
0
2
1
4
0
5
2
0
0
0
0
0
0
0
0
0
4
0
0
2
0
0
0
0
0
0
0
0
0
6
0
0
6
3
0
0
0
0
0
0
0
DR
DR
Totals grouped in pairs, except for shallowest holes which are grouped to the 3 shallowest depths25 Chi sq = 2.7837df6
CR
37
59
90
38
18
15
12
63 p<
27
17
12
14
6665604566000006600000020000000
00000000000000
0023660003146
600026603016560023346400021600200140120002000010000000000000000000000000000000000000
0.83649808
6
56
3466
0134666
0000010
0000000
0000000
0000000
1014566
00021555202026460310646600142656100021660110013200200112000000020000000000000000
000000000000000000000000
CR 16cm Optimised Dose
1.3 1.6
DR
CR DR
Totals grouped ¡n pairs, except for shallowest holes which are grouped to the 3 shallowest depths
19
53
44 Chi sq = 12.994941df6
18
34
77
20
16
13
16 p<
17
12
6
0
0
0
0
6
0
0
0
0
6
5
0
0
0
0
6
2
0
0
0
0
6
2
0
0
0
0
6
6
6
4
0
0
0
0
0
5
6
3
5
0
0
0
0
0
6
5
3
4
0
0
0
0
0
0
6
6
6
5
3
0
0
0
0
0
0
0
0
6
5
4
4
5
2
2
0
0
0
0
0
0
0
2
4
3
4
2
4
0
0
0
0
0
0
0
0
1
2
2
4
0
0
1
0
0
0
0
0
0
0
1
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.04320225
16cm Half Dose
1.3 '1.6
CR
6
663466
13456002326000000000000
000000000000
00104566
000001343000040601004236000203360011226400000131
00000000000000110000000000000000000000000000000000000000
1
DR
CR DR
Totals grouped ¡n pairs, except for shallowest holes which are grouped to the 3 shallowest depths
7
16
52
50
25
22
17
19
45
51
41
28
16
12
Chisq = 20.95
df6
6
0
0
0
0
6
0
0
0
0
6
4
0
0
0
0
6
5
4
0
0
0
0
6
5
2
0
0
0
0
6
6
5
2
2
0
0
0
0
6
4
6
3
'l
0
0
0
0
0
6
5
5
2
1
0
0
0
0
0
6
6
6
6
4
3
1
0
0
0
0
0
0
0
4
4
2
5
0
3
0
0
0
0
0
0
0
0
3
2
2
4
4
1
0
0
0
0
0
0
0
0
3
1
0
2
0
0
2
0
0
0
0
0
0
0
4
0
0
1
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0.00186974p<
CR
3.
2,
't.
't.
0.
0.
0.
0.
0.
DR
CR DR
Totals grouped in pa¡rs, except for shallowest holes which are grouped to the 3 shallowest depths
Chi sq = 23'35df6
50
54
61
31
27
14
16
38
76
28
18
12
15
21
16cm Double Dose
1.3 'l
103566
00't435
313246
231266
005556
2101556
235002666
0140064456
01000033566
00000000254666
00000000000012
00000000000000
00000000000010
00000000000000
03456
01156
22366
20366
01166
200356
0011346
00000266
000002256
00000000166666
00000000000123
0000000000000110000000000000000000000000000
p< 0.00068628
